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A B S T R A C T
Background
The glycaemic index (GI) is a physiological measure of the ability of a carbohydrate to affect blood glucose. Interest is growing in the
low GI carbohydrate concept for the clinical management of people at risk of, or with established coronary heart disease. There is a
need to review the current evidence from randomised controlled trials (RCTs) in this area.
Objectives
To review evidence from RCTs assessing the relationship between the consumption of low GI diets and the effects on coronary heart
disease (CHD) and related risk factors in people who have established CHD or risk factors.
Search strategy
We searched CENTRAL on The Cochrane Library (Issue 2, 2006), MEDLINE (1966 to July 2006), EMBASE (1980 to July 2006)
and CINAHL (1982 to July 2006). We checked references and contacted experts in the field. No language restrictions were applied.
Selection criteria
We selected RCTs that assessed the effects of low GI diets, over a minimum of 4 weeks, on CHD and risk factors for CHD. Participants
included were adults with at least one major risk factor for CHD e.g. abnormal lipids, diabetes or being overweight or who had
previously been diagnosed with CHD.
Data collection and analysis
Two reviewers independently assessed trial quality and extracted data. Authors of the included studies were contacted for additional
information where necessary.
Main results
Twenty-one RCTs were included, with a total of 713 participants randomised. No studies were found that reported the effect of low GI
diets on CHDmortality or CHD events andmorbidity. All 21 included studies report the effect of low GI diets on risk factors for CHD.
Meta-analysis detected limited and weak evidence of slightly lower total cholesterol with low glycaemic index diets. However, when
only studies on diabetics were included in the analysis, no evidence of an effect on total cholesterol was found. There is little evidence
from the combination of studies in meta-analysis that low glycaemic index diets have an effect on LDL cholesterol, HDL cholesterol,
triglycerides, glycosylated haemoglobin (HbA1c), fasting glucose or fasting insulin levels. However, the majority of individual studies
do report slightly lower levels of glycosylated haemoglobin (HbA1c) with low GI diets.
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Authors’ conclusions
There is no evidence from RCTs to show an effect of low GI diets on coronary heart disease. Weak evidence for minor effects on some
CHD risk factors was found. Many of the trials identified were short-term, of poor quality and did not have sufficient power to detect
clinically important differences. The combined evidence from the studies suggests that any beneficial effect of low glycaemic index diets
on CHD and its risk factors is small. There is a need for well designed, adequately powered, randomised controlled studies, of greater
than 12 weeks duration to assess the true effects of low glycaemic index diets for CHD.
P L A I N L A N G U A G E S U M M A R Y
Low glycaemic index diets for coronary heart disease
The glycaemic index is a measure of the ability of a carbohydrate to affect blood glucose levels. While there are many randomised
controlled trials that have examined the relationship between low glycaemic index diets and coronary heart disease, most are of poor
methodological quality. There is little evidence from the randomised controlled trials to recommend that healthcare professionals should
prescribe low glycaemic index diets for the purpose of improving risk factors for CHD.
B A C K G R O U N D
In western society, coronary heart disease (CHD) is the major
cause of death and the prevalence of CHD is increasing worldwide
(Murray 1997). In the UK in 1997, there were 238 deaths from
CHD per 100,000 population (OHE 1999) and, in England and
Wales in 1996, 20% of men and 12% of women over 65 years of
age were treated for CHD by general practitioners (Carter 1999).
An association between CHD and dietary fat intake is well-docu-
mented but the role of dietary carbohydrate in CHD is not. There
is increasing evidence from observational non-randomised stud-
ies that the glycaemic index (GI) of dietary carbohydrates may be
important in disease prevention and control (Brand-Miller 2002;
Frost 2000; Leeds 2002; Rizkalla 2002). The World Health Or-
ganisation has recommended that dietary carbohydrates be classi-
fied according to their glycaemic index and that the methodology
for assessing the glycaemic index should be standardised (FAO/
WHO 1997).
The concept of glycaemic indexwas first proposed in 1981(Jenkins
1981). The glycaemic index of a dietary carbohydrate is an as-
sessment of its post-prandial effect on blood glucose. The lower
the glycaemic index, the smaller the effect of the carbohydrate on
post-prandial glucose levels. The GI classification is a standardised
comparison of the 2-hour post-prandial glucose response to 50g
of a carbohydrate with that of 50g of white bread or glucose, cal-
culated from the area under the glucose response curve. The GI of
white bread and of glucose is 100 and all other carbohydrate foods
have GI between 0 and 100. The GI of a carbohydrate depends
on its rate of intestinal absorption, which can be influenced by its
composition and ease of digestion (Frost 2000). Low glycaemic
index carbohydrates have lower 2-hour areas under the glucose
curve than white bread, while high glycaemic index foods have
higher areas.
Cooking and food preparation can modify the glycaemic index of
foods. Highly processed convenience foods tend to have high GI.
Cooked pulse vegetables have lowGI as their cell walls are resistant
to cooking. The intact cereal grains of rye and granary bread all
have low glycaemic indexes. However, when granary bread is pro-
cessed to wholemeal bread, the grains are disrupted giving higher
GI. Some examples ofGI of common carbohydrate foods are given
in Table 1 (Frost 2000).
Table 1. Glycaemic index values for food types
Food type Glycaemic index
White bread 100
Wholemeal bread 100
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Table 1. Glycaemic index values for food types (Continued)
Weetabix 100
Cornflakes 119
Porridge 87
Baked beans 69
Digestive biscuits 84
Apple 52
In 1995, the first international tables of glycaemic index were
published (Foster-Powell 1995). The tables were updated in 2002
(Foster-Powell 2002) and the methodology on their derivation
has also been reported (Jenkins 1981; Wolever 1990). The ta-
bles list GI of individual foods. Prior to the WHO 1997 report (
FAO/WHO1997) on dietary carbohydrates that standardised the
method of measurement of GI of foods, different groups used dif-
ferent techniques to calculate the area under the glucose response
curve. However, the published glycaemic index tables have pro-
vided conversion factors or have presented tables using different
methods alongside one another.
The glycaemic index of a mixed meal can be calculated from
the different proportions of each of the carbohydrate containing
foods and their individual glycaemic index values. For example,
when bread and beans are mixed in equal quantities, the resulting
glycaemic response is midway between that of bread alone and
beans alone (Wolever 1985; Wolever 1986). The addition of fat
to a mixed meal reduces the glycaemic response (Bornet 1987;
Coulston 1987; Wolever 1988) but the relative response of one
carbohydrate to another remains. For example, baked beans (69)
have a lower GI than white bread (100) so baked beans will always
give a lower glycaemic response than white bread when part of a
mixed meal. Alternatively, the glycaemic index for a mixed meal
can be measured from the area under the glucose response curve
of the mixed meal. However, both the quality and the quantity
of carbohydrate are associated in the response of an individual to
foods (Barclay 2005; Sheard 2004).
In a large prospective study a diet high in carbohydrates with high
GI were linked to the development of coronary heart disease in
women at 10-year follow-up (Liu 2000). Two cross-sectional stud-
ies have shown that low GI diets are associated with high density
lipoproteins (HDL) cholesterol concentrations (Ford 2001; Frost
1999b). In hyperlipidaemic subjects, low glycaemic index diets
have been shown to lower serum cholesterol and triglyceride levels
(Jenkins 1987a). Obesity is also a risk factor for CHD. Energy-
restricted diets based on low GI foods produced greater weight
loss in obese populations than did equivalent diets based on high
GI foods (Brand-Miller 2002). A systematic review assessing the
effect of a low glycaemic index diet in the management of diabetes
mellitus reported an average drop in HbA1c of 0.5 percent point
(Brand-Miller 2003). This is approximately half the drop seen in
the UK Prospective Diabetes Study study, which suggests a signif-
icant clinical impact of this intervention (UKPDS 35).
Patients with diabetes are predisposed to coronary heart disease.
Mortality rates from coronary heart disease are up to five times
higher than the general population for people with diabetes (DoH
2001). Low glycaemic index diets have been shown to lead to
improved glycaemic control as well as several metabolic parameters
such as blood lipids in people with diabetes (Frost 1994; Rizkalla
2002).
Reduced insulin sensitivity is one component of a cluster of
metabolic and cardiovascular factors which contribute to the
metabolic environment that predisposes to CHD (Reaven 1993)
and which are associated with altered post-prandial metabolism.
Insulin resistance is a condition in which the body does not re-
spond to the action of insulin although enough insulin is pro-
duced. There is evidence of reduced insulin sensitivity at diagnosis
in 60% of patients with CHD (Ferrannini 1991). Low GI diets
have been shown to improve insulin sensitivity (Frost 1998a). Al-
though the insulin response is not used to define glycaemic index,
the lower the glycaemic index of a food the more attenuated is the
insulin response to a standard test meal (Bornet 1987).
Given this suggestive evidence of benefit of low GI diets, largely
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from observational studies which may be prone to confounding
and other biases, a systematic review of the randomised trial evi-
dence was undertaken.
O B J E C T I V E S
The aim of this systematic review was to assess the effect of gly-
caemic index of carbohydrates or diet on total mortality, CHD
events and risk factors for coronary heart disease, using all avail-
able randomised controlled trials and concurrent controlled trials
and meta-analytic techniques when appropriate.
The primary question to be answered by the review was:
Do low glycaemic index diets reduce total mortality from CHD,
CHD events or risk factors for CHD in people diagnosed with
CHD or with at least one major risk factor for CHD?
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled studies (RCTs). Crossover studies and par-
allel studies were included and crossover trials analysed separately
within the meta-analysis. Trials were only included if outcome
data could be collected (by communication with authors when
necessary).
Types of participants
Non-institutionalised people (age >16) with at least onemajor risk
factor for coronary heart disease or with diagnosed coronary heart
disease were included. Participants were considered to be free-liv-
ing if they were out-patients and/or lived at home. However, chil-
dren (age <16 years) were excluded. Major risk factors for CHD
include abnormal lipid levels (HDL and low density lipoproteins
(LDL) cholesterol, triglycerides and total cholesterol), diabetes,
family history of CHD, raised blood pressure, hypertension, over-
weight (body mass index >25), abdominal obesity, impaired glu-
cose tolerance, reduced insulin sensitivity, insulin resistance, hy-
perinsulinaemia, hyperglycaemia, abnormal clotting factors.
Studies which reported participants with current or previous coro-
nary heart disease (which includesmyocardial infarction, coronary
artery bypass graft or percutaneous transluminal coronary angio-
plasty, or with angina pectoris or coronary artery disease defined by
angiography) were included. Studies which reported participants
on medication were included.
Participants could be of either sex but those studies in which par-
ticipants were reported to be pregnant or acutely ill e.g. those with
diagnosed cancer, those in preparation for or who had undergone
heart or renal transplants, with HIV or AIDS, on haemo- or peri-
toneal dialysis, or with any renal problem were excluded. Studies
which reported participants with congenital heart disease were ex-
cluded. Studies on participants who were institutionalised or who
were in-patients in hospitals, homes or clinics were excluded.
Types of interventions
The intervention had to be advice on diet or carbohydrate foods,
or a prescribed diet when the glycaemic index of the diet or carbo-
hydrate foodswere reported or compared and the effect on risk fac-
tors for CHD or CHD events or mortality were reported. Studies
needed to have a minimum of 4 weeks intervention period. Com-
parisons had to be between diets with similar overall carbohydrate
and fat levels and similar levels of energy and macronutrients.
Studies did not need to specifically aim to compare the effect
of glycaemic index of the diet but if the glycaemic indices were
reported and the diets had similar carbohydrate, fat and energy
levels, they were included. Studies which compared the effect of
lower GI diets or foods with any higher GI diets or foods were
included.
Metabolic ward studies, conducted on-inpatients, were not in-
cluded as the participants are not free-living. Studies were not in-
cluded if they were multiple component interventions which in-
cluded factors other than glycaemic index of the diet , unless the
effect of glycaemic index of diet could be separated out from the
other interventions.
Types of outcome measures
Primary outcomes
1. Total CHD mortality;
2. Combined CHD events and morbidity (to include fatal
and non fatal myocardial infarction, angina, unplanned coronary
artery bypass graft or percutaneous transluminal coronary
angioplasty);
3. Changes in the severity of major risk factors for CHD
including lipids (HDL, LDL cholesterol levels, triglycerides and
total cholesterol), measures of diabetic control ( including
changes in medication, glycosylated haemoglobin, glucose
tolerance and control), overweight, blood pressure, insulin
resistance, insulin sensitivity, hyperinsulinaemia, hyperglycaemia.
Secondary outcomes
1. Quality of life;
2. Attitudes to diets; and
3. Problems such as bloating, nausea, weight gain, difficulty in
eating out, weight gain were noted.
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Search methods for identification of studies
Electronic searches
Searches were conducted in theCochraneCentral Register of Con-
trolledTrials (CENTRAL) inThe Cochrane Library (Issue 2 2006),
MEDLINE (1966 to July 2006), EMBASE (1980 to July 2006),
CINAHL (1982 to July 2006). See Appendix 1 for details of search
strategies. No language restrictions were applied
Searching other resources
1. The reference lists of all included studies were checked.
2. Known experts in the field were consulted.
3. Relevant published reviews were also sought as a source of
RCTs.
Data collection and analysis
Selection of studies
The titles and abstracts of retrieved records were scanned and were
only rejected if the reviewer could determine that they definitely
did not meet the inclusion criteria. Full texts were obtained for
any that could not be rejected with certainty. Each paper was then
assessed independently by two reviewers. An in/out form was used
to assess the inclusion (or otherwise) of full papers into the review.
If a trial was excluded after the full paper has been obtained, a
record of the study and reason for exclusion was recorded.
Data extraction and management
Original reports of trial results were extracted by two reviewers
independently. Differences between reviewers’ extraction results
were resolved by discussion and, when necessary, in consultation
with a third reviewer.
Data was extracted as follows and is reported in the characterisitics
of included studies table:
1. General information: published/unpublished, title, authors,
source, country, year of publication, duplicate publications;
2. Trial characteristics: design, duration, randomisation (and
method), allocation concealment (and method), blinding
(outcome assessors), check of blinding;
3. Intervention: dietary information/diet provided, length of
intervention, comparison interventions, method of calculating
glycaemic index;
4. Participants: sampling (random/convenience), exclusion
criteria, total number and number in comparison groups,
gender/age, diagnosis of CHD or risk factors, similarity of
groups at baseline, withdrawals/losses to follow-up, assessment of
compliance, medications used, smoking status when provided;
5. Outcomes: outcomes as specified above, the main outcome
assessed in the study, other events, length of follow-up;
6. Results: for outcomes and times of assessment.
Assessment of risk of bias in included studies
The quality of each trial was assessed based largely on the quality
criteria specified in the Cochrane Reviewers Handbook (Section
4.1.6). Trial quality was independently assessed by two reviewers.
Studies were not excluded on the basis of a low quality score. In
particular the following factors were examined.
1.Methodof randomisation: each factorwasmarked as ’done’, ’not
done’ or ’unclear’. Could the study be described as randomised
(including use of words such as “random”, “randomly” and “ran-
domisation”)?
Did the study describe the method of randomisation and was it
an appropriate method? A method to determine the sequence of
randomisation was regarded as appropriate if it allowed each study
participant to have the same chance of receiving each intervention
and the investigators could not predict which treatment was next.
Methods of allocation using date of birth, date of admission, hos-
pital numbers, or alternation were not regarded as appropriate.
2. Concealment of allocation: scored A (adequate), B (unclear), C
(inadequate), following criteria adopted from the Cochrane Re-
viewer’s Handbook (Section 4.1.6) and Schulz 1995.
A - Adequate measures to conceal allocations such as central ran-
domisation; serially numbered, opaque, sealed envelopes; or other
descriptions with convincing concealment.
B - Unclearly concealed trials, in which the authors either did not
report allocation concealment at all, or reported an approach that
did not fall into one of the categories in (A).
C - Inadequately concealed trials, in which the method of alloca-
tion was not concealed, such as alteration methods or use of case
record numbers.
3. Blinding: each factor was marked as ’done’, ’not done’ or ’un-
clear’. With lifestyle interventions, such as the topic for this re-
view, it is difficult to blind participants and those providing di-
etary advice, so this was not sought. However, it is possible to
blind outcome assessors and this was marked as ’done’, ’not done’
or ’unclear’.
4. Intention-to-treat analysis: was marked as ’done’, ’not done’ or
’unclear’. Whether an intention-to-treat analysis was possible on
all patients from the published data (i.e. whether there were any
exclusions from the trial after randomisation) and the number of
patients who were lost to follow-up. If there were no withdrawals
it should be stated in the article. An intention-to-treat analysis was
considered adequate if outcome data was analysed for all partici-
pants randomised.
Based on these criteria, studies were subdivided into the following
three categories (see Cochrane Handbook, section 6.7.1):
A - all quality criteria met: low risk of bias.
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B - one or more of the quality criteria only partly met: moderate
risk of bias.
C - one or more criteria not met: high risk of bias.
Data synthesis
For the purposes of pooling data, serum and plasma cholesterol
measurements were converted to units of mmol/L. In some studies
outcome data were reported in mg/dL. This was converted to
mmol/L by multiplying by conversion factors of 0.0259 for total,
HDL and LDL cholesterol; 0.0113 for triglycerides; and 0.0555
for glucose (JAMA 2004). When insulin was reported in µIU/mL
itwas converted to pmol/Lbymultiplying by a conversion factor of
6.945 (JAMA 2004). Where body weight was reported in pounds
it was converted to kilograms bymultiplying by a conversion factor
of 0.45.
Fasting glucose outcomes were reported in the studies as either
blood glucose, serum glucose or plasma glucose. All have been
pooled in the meta-analysis after conversion to the same units
of measurement (mmol/L), as the pooled analysis examines the
differences between the values.
When data were available, sufficiently similar and of sufficient
quality, statistical analyses were performed using the RevMan soft-
ware. Heterogeneity between trial results was tested for using a
standard chi-squared test. A p-value <0.1 was used to indicate that
significant heterogeneity was present. Tests of heterogeneity were
used for examining whether the observed variation in study results
was compatible with variation expected with chance alone. If het-
erogeneity was found, then data were not pooled. We indicated in
our protocol that primary outcomes of interest were:
1. Total mortality;
2. Cardiovascular events and morbidity; and
3. Risk factors for CHD.
And that when appropriate, recorded post treatment values or
outcomes at the end of the study would be pooled using relative
risk for dichotomous outcomes and for continuously distributed
data weighted mean differences using a fixed-effect model.
No data on mortality or cardiovascular events were reported in the
studies, data was identified in the included trials for the following
outcomes:
• total cholesterol (mmol/L);
• HDL cholesterol (mmol/L);
• LDL cholesterol (mmol/L);
• triglycerides (mmol/L);
• body weight (kg);
• fasting glucose (mmol/L);
• fasting insulin (mmol/L);
• glycosylated haemoglobin/HbA1c (%);
• blood pressure;
• insulin resistance/insulin sensitivity.
By applying the principle for appropriate pooling that data from at
least three studies are required for meta-analysis it was determined
that sufficient data for pooling in this review existed only at the 4-
5 week, 12 week and end-of-study intervals. Therefore, no pooling
of outcome data other than at these three intervals was done.Meta-
analysis has not been performed when less than 3 studies reported
outcome data.
Data reported 4 to 5 week post-treatment for interventions of 4
or 5 weeks duration were pooled, including any 4 to 5 week data
from studies of longer duration.
Data reported 12 weeks post treatment for interventions of 12
weeks duration were pooled, including any 12 week data from
studies of longer duration.
Data reported at the end of the study (end-of-study-data) has
been combined irrespective of the length of the study. Table 2
summarizes the duration of each study.
Data from parallel and crossover studies have been combined
within the meta-analysis and have also been analysed separately.
Table 2. Summary of length of interventions (endpoints)
Study Length
Bouche 5 weeks
Brand 12 weeks
Calle-Pascual 4 weeks
Carels 20 weeks (follow-up at 1 yr)
Fontvielle 5 weeks
Frost 1994 12 weeks
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Table 2. Summary of length of interventions (endpoints) (Continued)
Frost 1996 4 weeks
Frost 2004 12 weeks
Giacco 24 weeks
Heilbronn 8 weeks
Jiminez-Cruz 6 weeks
Kabir 4 weeks
Komindr 4 weeks
Luscombe 4 weeks
Patel 4 weeks
Raatz 24 weeks
Sloth 10 weeks
Taghrid 4 weeks
Tshilias 6 months
Wolever 1992a 6 weeks
Wolever 2002 16 weeks
The data pooled in meta-analysis were final values. However, in
two studies, only change-from-baseline data was available. In one
study (Wolever 2002) only change-from-baseline data was avail-
able for total cholesterol, HDL cholesterol, LDL cholesterol, tria-
cylglycerols and body weight outcomes. One study reported only
change-from-baseline data for bodyweight (Raatz 2005). It can
be appropriate to combine final values and change-from-baseline
values (Cochrane 2002). For analyses that included the Wolever
and Raatz studies, change data was combined with the final values
from other studies. However, sensitivity analysis has also been con-
ducted in those cases in the meta-analysis in which these studies
contribute a significant amount to the overall pooled result, in or-
der to examine the influence of the change-from baseline data on
the pooled result. One study reported only baseline and change-
from-baseline values (Tsihlias 2000). In this case endpoint values
have been calculated and the standard deviation has been assumed
to be equivalent to the baseline standard deviation as the values
are similar. As three of the 15 studies substituted low GI carbo-
hydrates in only one meal per day the sensitivity of the results to
these studies has also been examined. The results were re-analysed
pooling only the data from the 12 ’whole-diet’ studies. The results
of sensitivity analysis are reported separately within each compar-
ison section.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
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The search yielded 4615 references. After reading titles and ab-
stracts 97 full papers were obtained for further examination. From
these 25 papers, reporting on 21 separate studies, met the inclu-
sion criteria.
Overview
Details of the studies are shown in the table of characteristics
of included studies. The column headed ’methods’ presents the
results of the quality assessment (see methods of the review). The
column headed ’notes’ includes details of the reported GI of the
diets.
Of the 21 included studies tenwere of randomised crossover design
(Bouche 2002; Brand 1991; Calle-Pascual 1988; Fontvielle 1992;
Jimenez-Cruz 2003a; Kabir 2002; Komindr 2001; Luscombe
1999; Taghrid 2004; Wolever 1992a) and 11 studies (Frost 1994;
Frost 1996;Giacco 2000;Heilbronn 2002; Tsihlias 2000;Wolever
2002; Carels 2005; Frost 2004; Patel 2004; Raatz 2005; Sloth
2004) were parallel randomised controlled trials.
Population and setting
In three studies participants were diagnosed with advanced coro-
nary heart disease (Frost 1996; Frost 2004; Patel 2004), and
eleven studies were on diabetics (Brand 1991; Calle-Pascual 1988;
Fontvielle 1992; Frost 1994; Giacco 2000; Kabir 2002; Komindr
2001; Luscombe 1999; Taghrid 2004; Tsihlias 2000; Wolever
1992a). In four studies, participants were overweight (Bouche
2002; Carels 2005; Raatz 2005; Sloth 2004), in two studies partic-
ipants were both diabetic and overweight (Jimenez-Cruz 2003a;
Heilbronn 2002) and in one other study they had impaired glu-
cose tolerance and at least one risk factor for diabetes (Wolever
2002).
Of the eleven studies in which the participants were diagnosed
with diabetes: in eight studies, the participants had Type 2 diabetes
(NIDDM) (Brand 1991; Frost 1994; Kabir 2002; Komindr 2001;
Luscombe 1999; Taghrid 2004; Tsihlias 2000;Wolever 1992a); in
one study,Type 1diabetes (Giacco 2000); and two studies included
those with both Type 1 and Type 2 diabetes (Calle-Pascual 1988;
Fontvielle 1992). In the two studies in peoplewhowere reported to
be both overweight and diabetic, the participants were diagnosed
with Type 2 diabetes.
Studies were carried out in a range of countries: France (Bouche
2002; Fontvielle 1992; Kabir 2002; Taghrid 2004), Canada (
Tsihlias 2000; Wolever 1992a; Wolever 2002), Australia (Brand
1991; Heilbronn 2002; Luscombe 1999), UK (Frost 1994; Frost
1996; Frost 2004; Patel 2004), Italy (Giacco 2000), Spain (Calle-
Pascual 1988), Thailand (Komindr 2001),Denmark (Sloth 2004),
Mexico (Jimenez-Cruz 2003a) and the US (Carels 2005; Raatz
2005).
Intervention
Seventeen of the 21 studies compared the effect of low GI diets
with high GI diets. Three studies compared the effect of low GI
diets with other diets. Of these, one study compared the effect of
a low GI diet with standard diabetic dietary advice (Frost 1994),
one study compared low GI and healthy eating dietary advice with
healthy eating advice alone (Frost 2004), and one study compared
low GI dietary advice in addition to a behavioural weight loss
program with general nutritional advice as part of the same be-
havioural weight loss program (Carels 2005). One further study
(Giacco 2000) compared low and high fibre diets but the GI of
both diets was reported. In each of these studies, the GI of the diets
was reported and the control diets had a higher GI than the lowGI
diet groups, so for the purposes of this review these comparisons
have also been treated as low GI diet versus high GI diet.
In sixteen of the studies both the low and high GI diets introduced
were designed to be weight maintaining by keeping energy intake
constant before and after the study and between dietary groups. In
a further four studies, the dietswere intended tobeweight reducing
(Heilbronn 2002; Wolever 2002; Carels 2005; Raatz 2005). In
one study, weight loss advice was given to those with a BMI over
28 kg/m2 (Frost 2004).
The majority of the studies evaluated the effect of low GI car-
bohydrates in the whole diet. Three studies (Calle-Pascual 1988;
Kabir 2002; Tsihlias 2000) reported the effect of substitution of
low GI carbohydrates at one meal per day. Two of these studies (
Kabir 2002; Tsihlias 2000) compared the effect of high and low
GI breakfasts and one study (Calle-Pascual 1988) introduced low
GI foods at lunch only.
All studies included interventions over 4 weeks in length. In eleven
of the studies the intervention continued for 6 weeks or less (
Bouche 2002; Calle-Pascual 1988; Fontvielle 1992; Frost 1996;
Jimenez-Cruz 2003a; Kabir 2002; Komindr 2001; Luscombe
1999; Patel 2004; Taghrid 2004; Wolever 1992a). In three stud-
ies the intervention continued for 6 months (Giacco 2000; Raatz
2005; Tsihlias 2000). Some of the studies also reported outcomes
at intermediate timescales throughout the study. One study re-
ported follow-up at one year, after a 20 week intervention phase (
Carels 2005).
Outcomes
All of the studies reported major risk factors for CHD (criteria
as reported previously). None of the studies reported outcomes
relating to CHD mortality or morbidity, although one study did
report on the length of patients hospital stay after heart surgery.
Outcomes included body weight, fasting glucose, fasting insulin,
total cholesterol, HDL cholesterol, LDL cholesterol, triacylglyc-
erols, HbA1c (glycosylated haemoglobin), insulin sensitivity, in-
sulin resistance. Some studies reported all these outcomes. Others
reported only some of these outcomes.
Post-prandial glucose profiles were reported in a number of studies
but have not been included as an outcome for the meta-analysis
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because the methods of measuring the outcome are different. e.g.
some studies reported 3 hour Area Under a Curve data (AUC),
others 9 hour AUCs.
Two studies (Bouche 2002; Sloth 2004) reported on the accept-
ability of the diets as a secondary outcome.
Risk of bias in included studies
Overview
All 21 studies had some methodological weaknesses according to
criteria as set out in the Cochrane handbook. None fulfilled all
quality criteria.
Randomisation
Of the 21 studies, only four reported an appropriate method
of randomisation (Frost 1994; Frost 2004; Patel 2004; Wolever
2002). The remaining trials mentioned randomisation without
describing the process. Only one study mentioned an attempt at
allocation concealment (sealed envelopes were used but it is not
clear if these were opaque). Baseline differences between interven-
tion and control groups were discussed in most studies. One study
did not mention randomisation in the published paper, although a
crossover trial was described and confirmed by the authors (Calle-
Pascual 1988).
Blinding
One of the trials was reported to be double blinded (Kabir 2002).
However, no details of the methods employed or which stage of
the process was blinded were reported in the paper. None of the
trials reported blinding of outcome assessors (those taking sam-
ples or carrying out laboratory tests). None of the included studies
reported blinding of either the study participants or the providers
of diets and this factor was not included in the criteria for quality
assessment of studies for this review as it can be difficult to imple-
ment in lifestyle studies of the type included in the review.
Crossover studies
A carryover effect may occur in a crossover trial when the effects
of the treatment in the first period of the trial continue over to the
second period. In such cases, the results from the second period
may be inaccurate. A washout period is the time when no inter-
vention occurs between the two treatment periods and should be
long enough to allow the effects from the first treatment period to
completely disappear. For this review, baseline values prior to the
start of the second treatment stage have been used in the meta-
analysis when they have been reported in the studies. If baseline
values for the second treatment phase have not been reported, the
baseline values reported prior to the first treatment phase have
been used.
Of the 10 crossover trials, four did not report a washout period be-
tween diet phases (Calle-Pascual 1988; Fontvielle 1992; Komindr
2001; Luscombe 1999). This means that subjects may not have
started the second dietary phase with the same baseline values as
the first dietary phase. None of these four studies reported in-
termediate baseline values between the dietary phases so whether
there was a difference cannot be ascertained from the published
details. In the other six studies which were of crossover design,
the washout periods varied from 2 weeks to 6 weeks. Analysis has
been carried out on crossover and parallel studies separately to de-
termine if this made any difference to the overall results.
Potential confounders
All of the included studies reported body weight outcomes. The
sixteen studies which designed both the low and highGI diets to be
weight-maintaining reported no evidence of a difference in weight
change between the diet groups. However, one of these studies
specifically excluded participants if their weight varied by more
than 1% between the two dietary phases (Calle-Pascual 1988).
Additionally, the four studies which were designed to be weight-
reducing (Heilbronn 2002; Wolever 2002; Carels 2005; Raatz
2005) and one study that offered weight loss advice to those with
a BMI>28 kg/m2 reported no evidence for a difference in weight
loss between the low GI and high GI diet groups at the end of the
study.
The medication status of participants in the studies varied widely.
Nine studies reported that participants were taking medication. A
number of trials allowed medication dosages and/or regimens to
vary during the study period.
In five studies, participants were on oral hypoglycemics (sulpho-
nylureas or metformin). In four of these studies, the level of med-
ication for all participants remained constant throughout (Brand
1991; Kabir 2002; Komindr 2001; Luscombe 1999). In one study
(Tsihlias 2000), subjects were dropped if their dose of medication
changed within the first three months and their results excluded.
If the change occurred after 3 months, the subjects were dropped
from the study but the baseline and 3-month results were included
in the analysis.
In two trials (Calle-Pascual 1988; Giacco 2000) the participants
were reported to be taking insulin only. In one of these studies
the dose was only changed if absolutely necessary (Giacco 2000).
In the other study, patients were excluded if the insulin dose was
modified during the course of the study (Calle-Pascual 1988).
In a further study in which both Type 1 and Type 2 diabetes
patients were included (Fontvielle 1992), all the Type 1 patients
were on insulin and allowed to change insulin doses between study
periods. The Type 2 patients were on oral anti-diabetic medication
and maintained on their usual therapy throughout the study.
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In one study (Wolever 2002) one high GI subject was on thiazide
diuretics and one low GI subject was on beta-blockers.
One study (Heilbronn 2002) reported that those taking lipid-
lowering medication were requested to cease one month before
the trial but made no comment about whether participants were
on any oral hypoglycaemic medication. One study (Bouche 2002)
reported that none of the participants were on anymedication that
might affect glucose, insulin or lipid metabolism.
Ten studies did not report whether participants were on medica-
tion (Carels 2005; Frost 1994; Frost 1996; Frost 2004; Jimenez-
Cruz 2003a; Patel 2004; Raatz 2005; Sloth 2004; Taghrid 2004;
Wolever 1992a).
Energy and macronutrient content of the diets
In all of the studies, the energy and macronutrient content of the
high and low GI diets were designed to be equivalent.
Power
Power calculations were reported as incorporated in the design
of four of the 21 studies included in this review (Giacco 2000;
Tsihlias 2000; Wolever 2002; Sloth 2004). The sample size of the
study by Giacco (Giacco 2000) was based on 80% power to de-
tect a difference in HbA1c of >0.5% with P<0.05. The study by
Tshilias (Tsihlias 2000) was designed to have an 80% chance of
detecting a difference in HbA1c of 0.5% with P<0.05. Wolever (
Wolever 2002) determined the number of subjects in each group
based on 90% power to detect a difference in insulin sensitivity of
20% for P<0.05. Power calculations made before the Sloth study
(Sloth 2004) indicated that a total of 43 subjects were needed to
obtain a significant (P<0.05) difference in body weight of 2.0 kg
with a power of 90%. One study mentioned that power calcu-
lations had been done but did not report the level of power or
the difference it was designed to detect (Frost 2004). Some of the
included studies were small. None of the other included studies
reported power calculations. In five of the crossover studies the
number of subjects studied was less than 15 (Bouche 2002; Kabir
2002; Komindr 2001; Taghrid 2004; Wolever 1992a). In one fur-
ther crossover study, 36 were randomised but only 14 completed (
Jimenez-Cruz 2003a). Most of the studies reported multiple out-
comes in addition to the outcomes used as the basis for power
calculations.
Intention to treat (ITT) analysis
Only one of the 21 included studies reported an intention-to-
treat analysis along with an analysis of those compliant to diet (
Giacco 2000). However, the reported ITT analysis is considered
to be inadequate because it did not incorporate data for all subjects
randomised (63 subjects were randomised, but the ITT analysis
only took into account data from 54 subjects and the compliant-
to-diet analysis incorporated data from 46 subjects).
Quality assessment
None of the studies met all of the quality assessment parame-
ters specified for this review based on the criteria outlined in the
Cochrane Reviewer’s handbook and listed above in the section on
’Quality Assessment of Trials’ in ’Methods of the review’. Based
on these criteria all 21 of the included studies would be classified
as at high risk of bias. This means that one or more quality criteria
were not met. None of the studies were excluded on the basis of a
low quality score as all of the 21 included studies were graded at
the same level of quality based on the Cochrane criteria.
As all the trials were rated at the same level, sensitivity analysis on
the basis of quality was not carried out.
Effects of interventions
As there is a large volume of data for this review (from 21 studies
and for 10 different outcomes) a summary of the main results is
given here, by outcome.
All graphs accompanying the original review canbe accessed online
(by clicking on the ’Other versions’ link for the review in The
Cochrane Library).
Total cholesterol
Seventeen studies reported total cholesterol. There is some evi-
dence of a reduction in total cholesterol with low GI diets com-
pared to high HI diets when end-of-study values were pooled from
parallel studies and when parallel and crossover studies were com-
bined. The average reduction in total choletesterol from the pool-
ing of 17 studies was 0.16mmol/L (P = 0.02, 95% CI -0.29 to
-0.02; Analysis 1.1). The majority of individual studies reported
lower total cholesterol in the low GI group than in the high GI
group, however only one individual study reported a statistically
signficant effect.
When sensitivity analysis was conducted, pooling all crossover and
parallel studies which substituted low GI foods at all meals there
was little change when the end-of-study data was combined. The
low GI diet group gave a reduction in total cholesterol of 0.17
mmol/L compared to the high GI diet group (P=0.02, 95% CI
-0.32 to -0.02; Analysis 2.3). This compares with a reduction
of mean total cholesterol of 0.16 mmol/L for the low GI diet
compared to the high GI diet (Analysis 1.1) when all studies were
included in the meta-analysis. At 4-5 weeks (Analysis 2.1) and
at 12 weeks (Analysis 2.2) there was no evidence of a difference
between the low GI and high GI diets.
HDL cholesterol
Sixteen studies reported HDL as an outcome. Significant het-
erogeneity was seen in a number of comparisons so pooling was
not performed in those instances (Analysis 3.1). Almost all of the
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pooled comparisons suggested that there was no evidence of an
effect of low GI diets on HDL cholesterol.
Further sensitivity analysis showed that three studies using a paral-
lel design showed evidence of a difference between the low GI and
high GI diet groups at 4-5 weeks (-0.11 mmol/L, 95% CI -0.20
to -0.01, P=0.03; Analysis 4.1). However, the analysis was sub-
stantially weighted towards the study by Wolever 2002. This data
is the only result based on change from baseline data in the anal-
ysis. At 12 weeks, significant heterogeneity was found (P<0.01),
therefore no meta-analysis was performed (Analysis 4.2).
LDL cholesterol
Fourteen studies reported LDL cholesterol as an outcome. There
is borderline evidence of a reduction in LDL cholesterol on lowGI
diets compared to high GI diets when data from both parallel and
crossover studies at all endpoint intervals were pooled (14 studies;
Analysis 5.1), and a sensitivity analysis carried out (-0.16 mmol/L,
95%CI -0.32 to 0.00, P=0.05; Analysis 5.2). However, there is no
evidence of an effect from any of the other comparisons examined.
Triglycerides
Eighteen studies reported triglycerides as an outcome. None of
the comparisons detected any evidence of a difference in effect on
triglycerides between the low GI and high GI diets (Analysis 6.1).
Bodyweight
Seventeen studies reported body weight as an outcome. None of
the comparisons detected any evidence of a difference in effect on
body weight between the low GI and high GI diets. It should be
noted that in all of the studies both the low GI and high GI diets
were designed to deliver equivalent energy intake (Analysis 7.1).
Fasting glucose
Seventeen studies reported fasting glucose as an outcome. While
two comparisons using all the end-of study outcomes detected ev-
idence of higher fasting glucose in low GI groups (when parallel
studies alone were analysed and when both parallel and crossover
studies were combined), this effect disappeared in sensitivity anal-
yses (Analysis 8.1)
Fasting insulin
Nine studies reported fasting insulin as an outcome. None of the
comparisons detected any evidence of a difference in effect on
fasting insulin on lowGI diets compared to highGI diets (Analysis
9.1).
HbA1c (glycosylated haemoglobin)
Twelve studies reported HbA1c as an outcome. There is little ev-
idence of a beneficial effect of HbA1c on low GI diets compared
to high GI diets from pooled analysis of 12 studies (WMD -0.09,
95% CI -0.22 to 0.04; Analysis 10.1). None of the studies report
a significant intra-study difference between the high GI and low
GI diets. However, 11 of the 12 studies do report lower HbA1c
levels with low GI diets than with high GI diets.
Sensitivity analysis showed that at 12 weeks, pooled meta-analysis
of four parallel studies detected no evidence of an effect on HbA1c
of the low GI diet compared to the high GI diet (Analysis 10.2).
When analysis was conducted without the Frost 1996 study (be-
cause of poor randomisation) there was evidence of an effect of
low GI diets versus high GI diets (WMD -0.45, 95% CI -0.82 to
-0.09; Analysis 10.3).
Blood pressure
Two studies reported blood pressure outcomes. Sloth 2004 found
no significant differences (at significance level P<0.05) between
low GI and high GI groups in systolic (low GI 119 mmHg, SE
2; high GI 119 mmHg, SE 2) or diastolic (low GI 72 mmHg,
SE 2; high GI 74mmHg, SE 1) blood pressure after 10 weeks
intervention. Frost 2004 also reported no difference between the
groups in a 12 -week intervention comparing low GI diet with a
higher GI healthy eating control for either systolic (low GI 135
mmHg, SE 4; high GI 136 mmHg, SE 4, P=0.7135) or diastolic
blood pressure (low GI 73 mmHg, SE 2; high GI 76 mmHg, SE
2, P=0.2481).
Insulin resistance/insulin sensitivity
Three studies reported some measure of insulin resistance or in-
sulin sensitivity. One study reported the effect of low GI diets
compared to high GI diets on relative insulin resistance (HOMA-
R) (Sloth 2004). There was no significant difference between the
low GI (1.17, SE 0.15) and high GI (1.20, SE 0.10) groups af-
ter 10 weeks. One study reported the effect on insulin sensitiv-
ity (HOMA-S) (Frost 2004). There was no significant difference
(P=0.7057) between groups after 12 weeks in the low GI (107.73,
SE 11.96) and higher GI healthy eating control group (96.10, SE
7.54). One study reported change in insulin sensitivity (HOMA).
There was no difference between the lowGI and highGI groups in
change in insulin sensitivity (Raatz 2005). HOMA score changes
over 24 weeks were 0.09, SE 0.33 for the low GI group and 0.22,
SE 0.22 for the high GI group.
Sub-group analyses on diabetic participants
Sub-group analysis was also conducted on the studies in which the
participants were diabetics at baseline for the following outcomes:
total cholesterol, LDL-cholesterol,HDL-cholesterol, triglycerides,
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fasting glucose, fasting insulin, HbA1c. There was no evidence of
an effect of low glycaemic index diets compared to high glycaemic
diets on any of the risk factors for CHD in participants who were
diabetic.
Sub-group analyses on overweight participants
Sub-group analysis was also conducted on the studies in which
the participants were overweight at baseline for body weight as an
outcome only. There was no evidence of an effect of low glycaemic
index diets on body weight from the combined analysis of studies
in which the participants were overweight at baseline.
Secondary outcomes (quality of life measures)
Only two studies reported on quality of life measures (Bouche
2002). It was reported that the subjects followed the two dietary
periods (low and high GI) without any difficulty, although three
out of 11 subjects noted some flatulence with the low glycaemic
index diet. According to self-report, subjects lifestyles were un-
changed throughout the entire study. Raatz 2005 reported no ad-
verse effects throughout the study and that no participant with-
drew from the study due to side effects or health complications.
D I S C U S S I O N
This systematic review identified 21 randomised controlled trials
of greater than 4 weeks duration, which examined the effect of low
GI diets or foods compared with higher GI diets or foods onmajor
risk factors for CHD. Major risk factors for CHD that have been
examined are total cholesterol, LDL cholesterol,HDL cholesterol,
triglycerides, body weight, fasting glucose, fasting insulin, glycosy-
lated haemoglobin (HbA1c), body weight and insulin sensitivity
or insulin resistance. Most of the 21 studies were short-term with
11 of the studies being of less than 6 weeks duration.
No studies were found that reported the effect of low glycaemic
index diets on CHD mortality or on CHD events and morbidity.
Of the 21 included studies, 11 were parallel studies and 10 were
crossover studies. The crossover studies varied in quality with vari-
ations in the washout interval between the studies. Some studies
reported no washout at all so there may have been baseline differ-
ences between the groups evaluated.
Data from the studies was pooled for meta-analysis at 4 weeks
and at 12 weeks. As there was substantially more end-of-trial data,
this was also pooled irrespective of the duration of the study. Such
pooling of end-of-trial data from widely varying lengths of treat-
ment has limitations as the size of an effect of intervention can vary
with the length of the study. However, for this review it provided
more data in order to determine if there was any evidence of an
effect.
The poor methodological quality (according to Cochrane criteria)
of most of the included studies makes overall interpretation of the
data difficult. The results should be treated with caution because
the methodological quality of the included studies does not meet
the criteria specified in the Cochrane handbook, the trials differ
widely in terms of medication regimens for participants and most
of the studies are relatively small andmay not have sufficient power
to detect the small changes in outcomes specified. While some of
the studies did report power calculations, power was usually only
reported for one of the outcomes in the study. However, many
of the studies reported small changes in multiple outcomes and
power calculations were generally not reported for each outcome.
This review has provided substantial data on which to base power
calculations for the outcomes of future studies in this area.
Of particular concern is the variable reporting of risk factor out-
comes. It is possible that reporting bias in selection of outcomes
demonstrating favourable effects for low GI diets has occurred.
It seems likely that all trials would have measured all the major
outcomes (with the exception of serum insulin) specified in this
review but this cannot be determined without access to the origi-
nal trial protocols.
There is some evidence of a reduction in total cholesterol with low
GI diets compared to high GI diets when end-of study values were
pooled from parallel studies and when parallel and crossover stud-
ies were combined. The average reduction in total cholesterol of -
0.16 mmol/L, P=0.02 (95% CI -0.29 to -0.02) is small compared
with effects of statins. The majority of individual studies reported
lower total cholesterol in the low GI group than in the high GI
group, however, few individual studies reported a significant ef-
fect. It is not possible from the data available to determine if the
lowering of total cholesterol is due to a reduction in either LDL
cholesterol or HDL cholesterol. There is insufficient evidence to
claim a reduction inHDLor LDL cholesterol on lowGI diets. The
reduction in total cholesterol is small. It is possible that an effect
has only been detected on total cholesterol because there are more
studies that report this outcome and that any underlying effects on
LDL or HDL cholesterol are too small to be detected. From a clin-
ical perspective, a large observational study (Stamler 2000) that
examined the relationship between baseline cholesterol levels and
long-term coronary and cardiovascular mortality showed a strong,
continuous, independent relationship between serum cholesterol
levels in young men and their long-term risk of CHD and CVD
death. It also found that young men with high cholesterol lev-
els (>6.2 mmol/L) also had an increased risk of CHD and CVD
death in the short term compared to those with relatively more
favourable (<5.2 mmol/L) cholesterol levels. The small changes in
total cholesterol seen on lowGI diets (-0.16mmol/L) are therefore
of debatable clinical relevance. The lower confidence interval of
the pooled effect excludes an effect as big as a 0.29 mmol/L reduc-
tion in total cholesterol, equivalent to about a 5% reduction. None
of the studies included in this review were adequately powered to
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accurately detect such small changes in cholesterol. Longer term,
well-designed, high quality studies of sufficient power to detect
relatively small - but clinically important - changes in cholesterol
are needed to clarify if there is a clinical benefit of low GI diets on
cholesterol. However, based on the data presented in this review
any effect of low GI diets on CHD risk factors is small.
There is little evidence of a beneficial effect of glycosylated
haemoglobin (HbA1c) on lowGI diets compared to high GI diets
from pooled analysis of 12 studies. None of the studies report a
statistically significant intra-study difference between the high GI
and low GI diets. However, 11 of the 12 studies do report lower
HbA1c levels with lowGI diets thanwith highGI diets. The lower
95% confidence interval of the effect indicates that benefits of the
order of a 0.22% reduction in HbA1c can be excluded. The UK
Prospective Diabetes Study (UKPDS 35) study in patients with
type 2 diabetes reported that any reduction in HbA1c is likely to
reduce the risk of diabetic complications. Each 1% reduction in
mean HbA1c was associated with reductions in risk of 21% for
any endpoint related to diabetes, 21% for deaths related to dia-
betes, 14% for myocardial infarction and 37% for microvascular
complications.
There were few studies included in this review that reported blood
pressure or insulin sensitivity or insulin resistance. Those that did
found no difference between low GI and high GI groups. None
of the comparisons detected any evidence of a difference in effect
on body weight between the low GI and high GI diets. This is
not surprising as in all of the studies both the low GI and high GI
diets were designed to deliver equivalent energy intake. Subgroup
analyses on studies with diabetic participants only found no evi-
dence of an effect of low GI diets on any risk factors for CHD. A
protocol has been registered with The Cochrane Library which will
examine a wider range of outcomes relevant to diabetics (Thomas
2006). For body weight as an outcome, subgroup analysis found
no effect of low GI diets compared to high GI diets in studies
in which participants were overweight before the study. Another
Cochrane review has examined specifically the effect of glycaemic
index of diets on body weight. (Thomas 2007).
It should be noted that the GI of the low and high GI diets was
measured inmost of the studies by, for example, fooddiaries. These
measured values showed considerable variation. The method of
measuring GI of individual foods was standardised in 1997 (FAO/
WHO 1997). However, even studies that were conducted post-
1997 reported marked differences in the measured GI of the low
GI and high GI diets. The measured values are given in the ’char-
acteristics of included studies’ table of this review in the ’notes’
section. For example, in the study by Luscombe (Luscombe 1999)
the measured GI of the low GI diet was 43 units and themeasured
GI of the high GI diet was 63 units. In the study by Tshilias (
Tsihlias 2000) the GI of the low GI diet was 75.8, which is much
higher than for the high GI diet in the Luscombe study. In other
studies, the difference in measured GI of the low and high GI
diets was small. For example, in one study (Wolever 2002) the
low GI diet had a measured GI of 54.4 and the high GI diet had
a measured GI of 59.3. All studies which compared low GI diets
or foods with higher GI diets or foods have been included in this
review irrespective of the actual GI of the diet.
The differences in measured GI of the diets may be due to differ-
ences in the carbohydrate content of the diets. However, there is
some debate about the accurate measurement of GI in the diet.
Most of the lowGI diets used in the studies in this review are based
on mixed meals. It has been demonstrated that the GI of mixed
meals predicted by table values does not predict the measured
GI and that fat and protein content, or energy content of mixed
meals are more strongly correlated with the GI of mixed meals
than carbohydrate content (Flint 2004). Additionally, it has been
reported that most current food frequency questionnaires (FFQs)
are not constructed for the purpose of measuring glycemic index
and have not been validated for the measurement of glycaemic
index (Barclay 2006).
Sensitivity analysis was conducted in all analyses to remove those
studies which only replaced foods with low GI foods at one meal
a day and pool only those studies which implemented a low GI
diet at all meals ’whole-diet studies’. These sensitivity analyses had
little effect on the overall results.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The evidence from controlled trials that low glycaemic index diets
reduce coronary heart disease and CHD risk factors is weak. There
may be a slight reduction in total cholesterol on low GI diets.
Of the trials that met the review criteria, there were many poor
quality studies. Many of the trials identified were short-term and
conducted on small sample sizes. There is insufficient evidence
that healthcare professionals should prescribe low GI diets for the
purpose of reducing risk factors for CHD.
Implications for research
There is a need forwell-designed, adequately powered, randomised
controlled studies, of greater than 12 weeks duration to assess
the usefulness of low glycaemic index diets for the reduction of
coronary heart disease. This review provides data that can be used
to calculate adequate power for future studies.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bouche 2002
Methods Study design: Randomised crossover study
Random allocation: Unclear
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 5 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Overweight
Exclusion criteria: Abnormal renal, hepatic or thyroid function
Medications used: None that might affect glucose, insulin or lipid metabolism
Smoking status: Not reported
n =11 randomised, 11 completed
Mean age: 46 +/- 3 (SE) (mean age)
Male/female ratio: all male
Baseline characteristics: Reported
Geographical location: France
Interventions Intervention: LowGI diet . In the lowGI period, carbohydrate items with a GI< 45%were recommended.
Over a run-in period of 15 days subjects received individual counseling by a dietitian. Dietary intake was
prescribed individually according to data from dietary questionnaires ( 3 day recall).
Comparison interventions: High GI diet . In the high GI period, foods with a GI > 60% were recom-
mended. Prescribed individually, as for Low GI diet.
Washout interval (for crossover studies) : 5 weeks.
Assessment of dietary compliance: Patients were asked to complete a food diary on the last 7 days of each
dietary period.
Comparison of total energy and macronutrient intakes: Reported
Outcomes Main outcomes:
Fasting plasma glucose, body weight, glycosylated haemoglobin, Fasting plasma cholesterol, LDL-choles-
terol, plasma triglycerides
Other outcomes:
Urinary glucose, very-low density lipoprotein triglycerides and cholesterol, HDL cholesterol subfractions,
8-hr profiles of plasma glucose, insulin, C-peptide and triglycerides
Notes Reported GI of diets: Low GI diet 41.0+/-1 %, High GI diet 71.3 +/- 1.3 %.
Risk of bias
Item Authors’ judgement Description
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Bouche 2002 (Continued)
Allocation concealment? Unclear B - Unclear
Brand 1991
Methods Study design: Randomised crossover study
Random allocation: Unclear
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 12 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Subjects with well-controlled non-insulin dependent diabetes
Exclusion criteria: Those on any medication other than oral hypoglycaemic agents
Medications used: 10/16 subjects were taking oral hypoglycaemic agents (sulphonylureas). Medication
was not altered during the study.
Smoking status: Not reported
n =16 randomised, 16 completed
Mean age: 62+/- 9 (SD) years (mean age)
Male/female ratio: 62%/38%
Baseline characteristics: Reported
Geographical location: Australia
Interventions Intervention: Low GI diet . Before the study and then at weekly intervals throughout both dietary periods,
the subjects were given dietary counseling in their own homes. Each diet was prescribed individually
according to data obtained from a 4-day weighed record to maintain constant energy intake and nutrient
proportions.
Comparison interventions: High GI diet , prescribed individually as for Low GI diet.
Washout interval (for crossover studies) : 3 weeks
Assessment of dietary compliance: 4-day (Wed-Sat) weighed food record made at the completion of each
dietary period.
Comparison of total energy and macronutrient intakes: Reported
Outcomes Main outcomes:
Fasting plasma glucose, Fasting plasma insulin, Fasting total cholesterol, HDL-cholesterol, LDL-choles-
terol, Fasting triacylglycerols, Body weight
Other outcomes:
Total fat mass, postprandial plasma glucose and insulin profiles and AUCs, fructosamine, plasma leptin,
hepatic glucose production, insulin secretion and sensitivity, gene expression of genes involved
in adipocyte differentiation and lipid metabolism.
Notes Reported GI of diets: Low GI diet 77+/- 3 (mean), High GI diet 90+/- 1 (mean).
Risk of bias
Item Authors’ judgement Description
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Brand 1991 (Continued)
Allocation concealment? Unclear B - Unclear
Calle-Pascual 1988
Methods Study design: Randomised crossover study
Random allocation: Unclear
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 4 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Diabetes (Type 1 and type 2)
Exclusion criteria: If HbA1c not stable over past 4 months)
Medications used: All patients were treated with insulin. Patients were excluded If insulin dose was
modified during the course of the study.
Smoking status: Not reported
n = 34 randomised, 24 completed
Mean age: Type 1 patients 25 +/- 4 (SD) years, Type 2 patients 59 +/- 8 (SD) years.
Male/female ratio: not reported
Baseline characteristics: Not reported
Geographical location: Spain
Interventions Intervention: Low GI carbohydrates at lunch. Patients were given a diet with a high carbohydrate (60%),
low fat (20%) content with 25% of carbohydrates supplied at lunch in the form of 5 foods with GI ranged
between 29 and 36.
Comparison interventions: High GI carbohydrates at lunch. Patients were given a diet with a high car-
bohydrate (60%), low fat (20%) content with 25% of carbohydrates supplied at lunch in the form of 5
foods with GI ranged between 50 and 92.
Washout interval (for crossover studies) : None reported
Assessment of dietary compliance: Not reported
Comparison of total energy and macronutrient intakes: Reported
Outcomes Main outcomes:
glycosylated haemoglobin.
Other outcomes: postprandial glucose
Notes Reported GI of individual low GI carbohydrates supplied at lunch ranged between 29 and 36. GI of
individual high GI carbohydrates supplied at lunch ranged between 29 and 36.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Carels 2005
Methods Study design: Parallel RCT
Random allocation: Unclear
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 20 weeks (with follow-up after 1 year)
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Obese subjects (BMI >30 kg/m2)
Exclusion criteria: Cardiovascular disease, musculoskeletal problems, insulin-dependent diabetes or un-
controlled Type 2 diabetes, elevated resting blood pressure (>100 mm Hg).
Smoking status: Smokers were excluded.
n = 53 randomised, 38 completed
Mean age: Control group 43.5 (SD = 9.83) GI group 43.2 (SD = 9.02) years
Male/female ratio: Control (BWLP) 88.5% female, GI group (BWLP + GI) 77.8% female.
Baseline characteristics: Reported
Geographical location: USA
Interventions Intervention: Behavioural weight loss program and lowGI diet. BWLP as detailed below with the addition
of GI education with emphasis on a low-fat, low GI diet.
Comparison interventions: Behavioural weight loss program only (BWLP). The program is a weight
management program aimed at chieving gradual weight loss, increasing physical activity and reducing
energy and fat intake. Nutritional information was generally consistent with the GI education program
but included only limited discussion of carbohydrates and no reference to GI or GI related constructs.
Assessment of dietary compliance: 4-day food records at baseline and posttreatment.
Comparison of total energy and macronutrient intakes: Reported
Outcomes Main outcomes:
Body weight
Other outcomes:
BMI, body fat
Notes Reported GI of diets (at posttreatment): BWLP +GI 51.5 (SD=4.7) (mean), Control BWLP only 56.5
(SD=4.3) (mean).
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Fontvielle 1992
Methods Study design: Randomised crossover study
Random allocation: Unclear
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 5 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Subjects with well-controlled diabetes (12 Type 1, 6 Type 2)
Exclusion criteria: Not reported
Medications used: All 12 Type 1 patients were on insulin and allowed to change their insulin doses between
study periods.
All 6 Type 2 patients were treated with oral anti-diabetic drugs and maintained on their usual therapy
over both study periods.
Smoking status: Not reported
n =18 randomised, 18 completed
Mean age: All subjects = 47.2 +/- 11.6 (SD) (Type 1 = 42.7 +/- 10.3 (SD), Type 2 = 56.3 +/- 8.4)
Male/female ratio: 66.7%: 33.3%
Baseline characteristics: Not reported
Geographical location: France
Interventions Intervention: Low GI diet . Each diet was prescribed individually according to data obtained from a
baseline diet inquiry ( 7-day recall technique)tomaintain the initial energy intake and nutrient proportions
constant throughout the study.
Comparison interventions: High GI diet, prescribed individually as for Low GI diet.
Washout interval (for crossover studies) : none reported
Assessment of dietary compliance: 7-day food diary made at the completion of each dietary period.
Comparison of total energy and macronutrient intakes: Reported
Outcomes Main outcomes:
Fasting plasma glucose, fasting blood glucose, total plasma cholesterol, plasma HDL-cholesterol,plasma
triglycerides, glycosylated haemoglobin, body weight
Other outcomes:
Insulin dose, postprandial blood glucose, mean blood glucose, fructosamine, phospholipids, apolipopro-
tein A1, apolipoprotein B, insulin binding to erythrocytes.
Notes Reported GI of diets: Low GI diet 38.1 +/- 5.3% (mean), High GI diet 64.2 +/- 3.1% (mean).
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Frost 1994
Methods Study design: RCT
Random allocation: Adequate (random number tables)
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 12 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Type 2 diabetes (newly diagnosed)
Exclusion criteria: Pregnant or lactating women, those aged >70 years, those with other endocrine or lipid
disorders, those who had received dietary advice in the past, those judged to need oral hypoglycaemic or
insulin therapy and patients where there was a language barrier.
Medications used: None reported
Smoking status: Not reported
n = 60 randomised, 51 completed. Control (standard diabetic dietary advice) group: baseline n = 30, end
n = 26. Intervention (Low GI) group: baseline n = 30, end n = 25
Mean age: Control (standard advice) 56 +/- 3 years, Low GI 54+/- 2 years
Male/female ratio: Control (standard advice) 76.9 %/ 23.1%
Baseline characteristics: Reported
Geographical location: England
Interventions Intervention: Low GI diet . The low GI group received standard advice based on the British Diabetic
Association dietary recommendations and further verbal and written information on low GI foods. The
low glycaemic information was highlighted both verbally and in written form as the main aim of the diet.
A dietary history was taken to give advice on meal patterns and how best to fit these recommendations
into the subject’s normal life.
Comparison interventions: Standard diabetic dietary advice. This group received advice based on the
British Diabetic Association recommendations only.
Assessment of dietary compliance: Two 3-day food diaries, one at the end of week 4 and the other at the
end of week 12. The results were expressed as the mean of the two food diaries.
Comparison of total energy and macronutrient intakes: Reported
Outcomes Main outcomes: Fasting blood glucose, cholesterol, triglycerides, LDL-cholesterol, HDL cholesterol.
Other outcomes: Fructosamine
Notes Reported GI of diets: Low GI diet 73.9% (mean), Standard diet 86.3% (mean).
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Frost 1996
Methods Study design: RCT
Random allocation: Unclear
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 4 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Advanced coronary artery disease
Exclusion criteria: Not reported
Medications used: Not reported
Smoking status: Not reported
n = 32 (?) randomised, 30 completed
Control (High GI group): baseline n = 15, end n = 15. Intervention (Low GI) group: baseline n = 15,
end n = 15
Mean age: High GI = 63.5+/- 2.0 years, Low GI = 61.8+/-1.7 years
Male/female ratio: High GI = 73.3/26.7 %, Low GI = 80/20 %.
Baseline characteristics: Reported
Geographical location: England
Interventions Intervention: Low GI diet . Low GI subjects were encouraged to change one of their major carbohydrate
sources to a low-glycaemic carbohydrate at each meal. All subjects completed a 7-day diary of habitual
dietary intake. Dietary advice was based on the subjects normal energy and macronutrient intake. All
subjects were given an individualised dietary plan and written advice. In both groups, subjects were given
financial support over the period of the study to meet the costs of dietary change.
Comparison interventions: High GI diet. High GI subjects were encouraged to avoid Low Glycaemic
Index foods and to eat rapidly absorbed carbohydrates and were given an individualised dietary plan.
reported
Assessment of dietary compliance: Assessed at week 1 and week 4 but method not reported.
Comparison of total energy and macronutrient intakes: Reported
Outcomes Main outcomes: Fasting blood glucose, Fasting insulin, serum total cholesterol, serum triglycerides, serum
LDL-cholesterol, serum HDL cholesterol, body weight.
Other outcomes: insulin stimulated glucose uptake in isolated adipocytes, insulin incremental area under
the OGTT curve, glucose incremental area under the OGTT curve, free fatty acids
Notes Reported GI of diets: Low GI diet Week 1 72+/-2 %, Week 4 76+/- 1 %, High GI diet Week 1 90 +/-
3%, Week 4 91+/- 1%.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Frost 2004
Methods Study design: Parallel RCT
Random allocation: Adequate (random numbers)
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 12 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Participants had diagnosed myocardial infarction, unstable angina or
coronary artery disease.
Exclusion criteria: Cardiomyopathy, serious organ disease, systemic illness, chronic alcohol abuse, serious
psychiatric illness, poor compliance with food diaries or failed medical screening.
Medications used: Not reported
Smoking status: Not reported
n = 57 randomised, 55 completed
Mean age: LGI group 63.6 (SD=9.4), Control (healthy eating) group 61.8 (SD = 9.0).
Male/female ratio: Low GI group 23/26. Control (healthy eating) 25/29.
Baseline characteristics: Reported
Geographical location: UK
Interventions Intervention: Low GI diet - healthy eating advice emphasising low GI carbohydrates. Healthy eating
advice was similar to that in the control group except that the use of at least one low GI food (carbohydrate
with GI <85) at each meal was recommended.
Comparison interventions: Healthy eating diet . The diet was based on current health education guidelines
advocated by the COMA panel. The aim of the diet was to provide a diet with 50% carbohydrate and
35% of total energy as fat. Unrefined high cereal fibre carbohydrates were encouraged and a daily target
of five portions of fruit and vegetables was set.
Assessment of dietary compliance: 7 day diet diary recorded on 4 occasions during the study.
Comparison of total energy and macronutrient intakes: Reported
Outcomes Main outcomes:
Fasting glucose, fasting insulin, glycosylated hemoglobin, total cholesterol, LDL cholesterol, HDL choles-
terol, triglycerides, body weight
Other outcomes: systolic blood pressure, diastolic blood pressure.
Notes Reported GI of diets (at posttreatment): Low GI group 71 (SE 1), control group (healthy eating) 81 (SE
1). The between group difference was significant ar p<0.05.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Giacco 2000
Methods Study design: RCT
Random allocation: Unclear
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 24 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Reported but inadequate
Participants Diagnosis of CHD or risk factors: Type 1 diabetes
Exclusion criteria: Those with renal failure, liver disease, symptomatic CVD, glycosylated haemoglobin
<7, or >10 %.
Medications used: Insulin ( 2 or more injections per day). The dose was only changed if plasma glucose
concentrations increased on repeated occasions or hypoglycaemic episodes increased regularly.
Smoking status: Not reported
n = 63 randomised, 30 completed
Control (Low fibre, high GI group): baseline n = 31, end n = 22. Intervention (High fibre, Low GI)
group: baseline n = 32, end n = 24
Mean age: 28.2+/- 9.5 years
Male/female ratio: Low fibre, (High GI) = 36.0/64.0 %, High fibre (Low GI) = 41.4/58.6 %.
Baseline characteristics: Reported
Geographical location: Italy
Interventions Intervention: High fibre (Low GI ) diet . Patients on the HF diet were advised to consume HF legumes,
fruit and vegetables. All patients followed an intensive dietary education program that included diet
history, a personalized diet, two 1-hour educational sessions with a dietitian. The test diet was prescribed
to maintain energy and macronutrient intake. In addition individuals met with a dietitian once a month.
Comparison interventions: Low fibre (High GI) diet. Low fibre, High GI subjects were encouraged to
limit legume consumption to less than once a week and to consume preferentially LF fruit and vegetables.
Other treatment was the same as for the HF, Low GI diet. Assessment of dietary compliance: monthly 7-
day food record Comparison of total energy and macronutrient intakes: Reported
Outcomes Main outcomes: Glycosylated haemoglobin, plasma triglycerides, plasma cholesterol, plasmaHDL-choles-
terol,body weight.
Other outcomes: mean daily plasma glucose, hypoglycaemic events, insulin dose.
Notes Reported (mean) GI of diets: High fibre (low GI) diet 70%, Low fibre , high GI diet 90%.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Heilbronn 2002
Methods Study design: RCT
Random allocation: Unclear
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 8 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Overweight subjects with Type 2 diabetes
Exclusion criteria: Those receiving treatment with oral hypoglycaemic agents, insulin or those with renal
or liver disease.
Medications used: Subjects taking lipid lowering medicine were requested to cease one month before the
trial.
Smoking status: Not reported
n = 56 randomised, 45 completed
Control (High GI group): baseline n = 21, end n = 21. Intervention (Low GI) group: baseline n = 24,
end n = 24
Mean age: High GI = 57.5+/- 2.0 years, Low GI = 56.0+/-2.0 years
Male/female ratio: High GI = 57.1/42.9 %, Low GI = 45.8/54.2 %.
Baseline characteristics: Reported
Geographical location: Australia
Interventions Intervention: Energy restricted Low GI diet. To maximise compliance, subjects were provided with ’key’
foods, including breakfast cereals, breads, biscuits and low fat protein foods. Subjects attended dietary
consultations every two weeks with the research dietitian to ensure compliance and were given detailed
instructions on how to manipulate the diets in keeping with appropriate Glycaemic index and saturated
fat contents.
Comparison interventions: Energy restricted High GI diet. Treatment as for Low GI above, replacing low
GI foods with high GI.
Assessment of dietary compliance: Three day dietary intake records were completed every two weeks.
Comparison of total energy and macronutrient intakes: Reported
Outcomes Main outcomes: Body weight, Fasting plasma glucose, Glycosylated haemoglobin, total serum cholesterol,
serum LDL cholesterol, serum HDL-cholesterol, serum triglycerides
Other outcomes:
Systolic BP, diastolic BP, Oral glucose tolerance test, area under glucose curve following oral GTT, urinary
glucose excretion.
Notes Reported GI of diets: Low GI diet 43%, High GI diet 75%.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Jimenez-Cruz 2003a
Methods Study design: Randomised crossover study
Random allocation: Unclear
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 6 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Type 2 diabetes
Exclusion criteria: Not reported
Medications used: Not reported
Smoking status: Not reported
n = 36 randomised, 14 completed
Mean age: 53 (SE 9) years.
Baseline characteristics: Reported
Geographical location: Mexico
Interventions Intervention: Low GI diet. Dietary instruction was provided on lower GI foods. Recommendations with
respect to the amount of carbohydrates were based on hte number of portions of grain, fruit, vegetables
and dairy products recommended in the Apple of Health illustration guide. Typical lower-GI foods were
oranges, beans, yogurt, pasta and corn tortillas.
Comparison interventions: High GI diet . The diet was as for the low GI diet described above but with
instructions on higher GI foods. Typical higher GI foods were corn flakes, white bread, potatoes and ripe
bananas.
Washout interval (for crossover studies) : 6 weeks
Assessment of dietary compliance: unweighed dietary intake diaries for 1 day during the first, fourth and
sixth week of the two study periods. Comparison of total energy and macronutrient intakes: Reported
Outcomes Main outcomes: fasting serum glucose, total cholesterol, LDL- cholesterol,HDL cholesterol, triglycerides,
glycosylated haemoglobin (A1c), body weight.
Other outcomes: BMI
Notes Reported GI of diets: Low GI diet 44 (SE 0.9), High GI diet 56 (SE 1.3). p=0.0001 (using Wilcoxon’s
rank-sum test to compare).
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Kabir 2002
Methods Study design: Randomised cross-over study
Random allocation: Unclear
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear (study described as double-blind but not clear who or what was
blinded)
Length of intervention: 4 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Type 2 diabetes
Exclusion criteria: Abnormal renal, hepatic, thyroid functions, blood cell count, gastrointestinal disorders
Medications used: 12/13 patients were on oral anti-diabetic agents (sulphonylurea and/or metformin)
. None of the patients were on insulin, 4 patients were being treated for hypertension with B-blockers,
ACE inhibitors, antidiuretics and/or calcium antagonists. Medication was kept constant throughout the
study.
Smoking status: Not reported
n = 13 randomised, 13 completed
Mean age: All subjects = 59+/-2 years
Male/female ratio: 100% male
Baseline characteristics: Reported
Geographical location: France
Interventions Intervention: Low GI breakfast composed of whole-grain bread and muesli containing B-glucan from
oats. The size of the breakfast was fixed before the study and based on each patient’s dietary record taken
before the study to maintain the initial caloric intake and nutrient proportions constant throughout the
study (recall technique). Patients received individual counseling by a dietitian concerning dietary food
intake and small group counseling sessions. Treatment foods for breakfast were provided to the subjects
and prescribed to meet 20% of daily energy requirements.
Comparison interventions: High GI breakfast composed of wholemeal bread and whole wheat breakfast
cereal. Other treatment the same as for low GI.
Washout interval (for crossover studies) : 15 days
Assessment of dietary compliance: 7-day fooddiary on the last 7 days of each treatment period.Comparison
of total energy and macronutrient intakes: Reported
Outcomes Main outcomes: Glycosylated haemoglobin, fasting plasma glucose, fasting plasma insulin, plasma HDL
cholesterol, total fasting plasma cholesterol, fasting plasma triglycerides, body weight .
Other outcomes: Effect on subject’s lifestyles, AUC plasma glucose (3h), AUC insulin (3h), mean to-
tal cholesterol (7h), mean triglycerides (7h), fructosamine, free fatty acids, apolipoprotein B, amount
of mRNA of leptin in abdominal adipose tissue, peroxisome proliferator activated receptor-gamma,
cholesterylester transfer protein mRNA amounts.
Notes Reported GI (of breakfasts only): Low GI 40%, High GI 64%.
Risk of bias
Item Authors’ judgement Description
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Kabir 2002 (Continued)
Allocation concealment? Unclear B - Unclear
Komindr 2001
Methods Study design: Randomised cross-over study
Random allocation: Unclear
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 4 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Type 2 diabetes
Exclusion criteria: Diabetic complications, inability to consume test diets or to keep detailed food records,
fasting plasma glucose outwith 140 to 280 mg/dL. Medications used: Oral hypoglycaemic agents but
number of participants using medication not specified.
Smoking status: Not reported
n =10 randomised, 10 completed
Mean age: not reported, age range 32-60 years
Male/female ratio: all female
Baseline characteristics: Reported
Geographical location: Thailand
Interventions Intervention: Low GI diet . Carbohydrate component of the diet consisted mainly of mungbean noodles
and partly of rice noodles. Test carbohydrates were supplied to participants.
Comparison interventions: High GI diet . The carbohydrate content of the diet consisted mainly of
glutinous rice and partly of rice-in-soup. Test carbohydrates were supplied to participants.
Washout interval (for crossover studies) : None reported
Assessment of dietary compliance: Not reported but pre-weighed test carbohydrates were supplied.
Comparison of total energy and macronutrient intakes: Reported
Outcomes Main outcomes:
Fasting plasma glucose, plasma insulin, HbA1c, body weight
Other outcomes:
BMI, waist to hip ratio,percentage of total body fat, serum albumin, hematocrit, diurnal plasma glucose,
integrated plasma glucose, diurnal serum insulin, integrated serum insulin, urinary glucose excretion
Notes Reported GI of individual carbohydrate food, not whole diet. Low GI diet - mungbean noodles 63, rice
noodles 76; High GI diet - glutinous rice 106.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Luscombe 1999
Methods Study design: Randomised cross-over study
Random allocation: Unclear
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 4 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Non-insulin dependent diabetes
Exclusion criteria: History of renal disease retinopathy or vascular problems
Medications used: 16/21 subjects were on oral anti-diabetic agents (sulphonylurea and/or metformin).
Drug dose was not altered during the study. None of the subjects were taking any drug known to affect
lipid metabolism.
Smoking status: Not reported
n = 21 randomised, 21 completed
Mean age: All subjects = 57.4+/-2.9 years
Male/female ratio: 66.7/33.3%
Baseline characteristics: Reported
Geographical location: Australia
Interventions Intervention: Low GI diet (high carbohydrate). Before the study, and at fortnightly intervals, subjects
received detailed dietary instructions on how tomanipulate the GI. Specific study foods, dietary guidelines
and menus were provided to help subjects maintain compliance. The diets for all subjects were individu-
alised to maintain constant energy intake. Comparison interventions: High GI diet (high carbohydrate).
Treatment as for low GI diet. Washout interval (for crossover studies) : No washout between diets.
Assessment of dietary compliance: 2-day weighed food records plus a 24h diet recall which were combined
for analysis and completed fortnightly throughout each dietary phase. Comparison of total energy and
macronutrient intakes: Reported
Outcomes Main outcomes: Body weight, fasting glucose, fasting insulin, total cholesterol, triacylglycerols, HDL-
cholesterol, LDL-cholesterol, glycated plasma protein.
Other outcomes:
fructosamine, 24h urinary excretion of glucose and C-peptide
Notes Calculated GI of diets: Low GI 43%, High GI 63%.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Patel 2004
Methods Study design: Parallel RCT
Random allocation: Adequate (random numbers)
Allocation concealment: Unclear (sealed envelopes were used but it is not reported if they were opaque).
Blinding of outcome assessors: Unclear
Length of intervention: 4 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Participants had angiographically proven coronary artery disease and
were awaiting coronary artery bypass surgery.
Exclusion criteria: Not reported
Medications used: Not reported
Smoking status: Not reported
Number randomised is not reported, 35 completed
Mean age: Low GI group 59 (SE=7), High GI group 61 (SE=6).
Male/female ratio: Low GI group 16/2, High GI group 13/4.
Baseline characteristics: Reported
Geographical location: UK
Interventions Intervention: Low GI diet . ’Heart health diet’ with the proportion of energy from carbohydrate 50% and
the proportion of energy from fat 35% and advice was given on a daily target of five portions of fruit and
veg. Additionally, there was emphasis on the use of low GI foods (carbohydrate with a GI <80. Participants
were asked to swap a carbohydrate at each meal for a low GI carbohydrate such as pasta, basmati rice,
wholegrain foods, granary breads, whole fruit, beans and pulse vegetables and milk.
Comparison interventions: High GI diet. The same ’heart health diet as decribed for the lowGI group was
used. Additionally, participants were asked to swap in highGI foods ( >90) such as white bread, cornflakes,
potatoes and told to avoid foods with GI <80 as listed above. Assessment of dietary compliance: 7-day
unweighed food diaries that were validated against estimated energy expenditure at week 1 and week 4.
Each recorded intake was reviewed with the patients and portion sizes estimated using a portion size atlas.
Comparison of total energy and macronutrient intakes: Reported
Outcomes Main outcomes:
Fasting glucose, fasting insulin, fasting cholesterol, fasting triglycerides, fasting LDL-cholesterol, fasting
HDL-cholesterol,
Other outcomes:
Notes Reported GI of diets: Low GI diet 74 (SE 1), High GI diet 90 (SE 2). Significant difference between the
groups p<0.05
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Raatz 2005
Methods Study design: Parallel RCT
Random allocation: Unclear
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 24 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Obese participants, BMI 30-40 kgm2. Exclusion criteria: Those taking
prescription medicines, with existing medical conditions or pregnancy.
Medications used: Individuals taking medication were excluded.
Smoking status: Not reported.
42 randomised to (to 3 groups), 12 week energy restricted diet prior to intervention, 22 completed, Low
GI group 6, High GI group 8, High fat group 8.
Mean age: not reported
Male/female ratio: Low GI group 7/3, High GI group 7/3.
Baseline characteristics: Reported
Geographical location: US
Interventions Intervention: Low GI diet . Low glycaemic load and glycaemic index diet (energy reduced). The fatty
acid distribution of the diets was 1:1:1 for the ratio of polyunsaturated to monounsaturated to saturated
fatty acids. The cholesterol content of the diets was constant at 100g/4184 kJ. Modifications in GI were
achieved by utilizing carbohydrate foods with a lower GI for the LGI diet. The energy level was designed
to promote a weight loss of 0.70 kg/wk.
Comparison interventions: High GI diet. As the low GI diet above except that low GI foods were not
used (it is not reported whether high GI foods were recommended). Assessment of dietary compliance:
5-day food records at weeks 12 and 24 of the GI intervention phase.
Comparison of total energy and macronutrient intakes: Reported
Outcomes Main outcomes: Change in body weight, change in insulin sensitivity (HOMA), change in serum insulin,
change in plasma glucose, change in plasma triglycerides.
Other outcomes:
change in BMI, change in body fat, change in lean body mass
Notes Reported GI of diets: Initially subjects in the low GI group consumed a lower GI diet (p=0.014 after 12
weeks of GI intervention), but at the end of the intervention (24 weeks), there was no difference in GI
between the 2 groups. No figures for GI of the diets were reported.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Sloth 2004
Methods Study design: Parallel RCT
Random allocation: Unclear
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 10 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Overweight women (BMI 25-30 kgm2).
Exclusion criteria: Outside age 20-40, BMI outside 25-30, body weight fluctuations, physiologic or
psychological illness, use of medication (except birth control pills), blood pressure >/= 159/99 mm Hg,
allergies, special diets, high alcohol intake, smokers, elite athletes, those planning to change physical
activity levels, pregnancy, lactation, those who were post-menopausal, those who had donated blood in
the past 3 months.
Medications used: Participants on medication were excluded. Smoking status: Smokers were excluded
Number randomised 55, 45 completed
Mean age: Low GI group 28.9 (SE=1.3), High GI group 30.8 (SE=1.3).
Male/female ratio: Low GI group all female, High GI group all female.
Baseline characteristics: Reported
Geographical location: Denmark
Interventions Intervention: Low GI diet . Ad libitum, high carbohydrate (55-60% of energy from carbohydrate), low
fat (</= 30% of energy from fat) diet, rich in LGI foods. Participants received carbohydrate-rich test foods
from the research group every week. In the Low GI diet group, the test foods were wholegrain wheat
bread, wholegrain rye bread, long-grain rice and pasta.
Comparison interventions: High GI diet. The diet was similar to the low GI diet described above, except
that high GI test foods were supplied by the research group every week. In the high GI diet group, the test
foods were wholemeal wheat bread, wholemeal rye bread, round grain rice and mashed potato powder.
Macronutrient composition was kept similar in the 2 groups by adjusting protein and fat intake with a
low-fat sour milk product and butter. Assessment of dietary compliance: 7-day weighed food diaries were
completed before entering the study and in weeks 5 and 10 of the study period.
Comparison of total energy and macronutrient intakes: Reported
Outcomes Main outcomes: Body weight,
Fasting glucose, fasting insulin, fasting cholesterol, fasting triglycerides, fasting LDL-cholesterol, fasting
HDL-cholesterol, Relative insulin resistance (HOMA-R).
Other outcomes:
General acceptability of the diets.
Notes Reported GI of diets: Low GI diet 78.6 (SE not reported), High GI diet 102.8 (SE not reported). The
figures above are for weighted glycaemic index determined from in vitro hydrolysis index.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Taghrid 2004
Methods Study design: Randomised cross-over study
Random allocation: Unclear
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 4 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Type 2 diabetes
Exclusion criteria: No information
Medications used: No information
Smoking status: No information
n = 12 randomised, 12 completed
Mean age: No information
Male/female ratio: 100% male
Baseline characteristics: Reported
Geographical location: France
Interventions Intervention: Low GI diet .
Comparison interventions: High GI diet.
Washout interval:
Two weeks.
Assessment of dietary compliance: No information
Comparison of total energy and macronutrient intakes: Reported
Outcomes Mainoutcomes: Bodyweight, fasting glucose, fasting insulin glycosylated haemoglobin, fasting cholesterol,
HDL cholesterol, LDL cholesterol, triacylglycerols.
Other outcomes:
Not yet published
Notes Calculated GI of diets: Low GI 39%, High GI 71%.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Tsihlias 2000
Methods Study design: RCT
Random allocation: Unclear
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 6 months
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Subjects with Type 2 diabetes for >6 months.
Exclusion criteria: pregnancy, aged <40 or > 80 years, biochemical evidence of impaired renal or hepatic
function, BMI > 36, glycosylated haemoglobin <6.5%, serum triacylglycerol >10 mmol/L.
Medications used: Subjects who were being treated with insulin or acarbose were excluded. Subjects on
a stable dose of metformin or sulphonylurea or both were included. Subjects with changes in the type
or dose of oral hypoglycaemic agent in the first 3 months were dropped from the study If the change
occurred after 3 months, the subjects were dropped from the study but the baseline and 3 month results
were included in the analysis (except for blood lipids results).
Smoking status: Not reported
n = 59 randomised, 46 completed
Control (High GI group): baseline n = 29, end n = 21. Intervention (Low GI) group: baseline n = 30,
end n = 25
Mean age: High GI = 28.0+/- 0.7 years, Low GI = 27.7+/-0.7 years
Male/female ratio: No significant difference between the study groups.
Baseline characteristics: Reported
Geographical location: Canada
Interventions Intervention: Low GI breakfast cereal. Treatment foods were provided to the subjects and prescribed to
meet 10-15% of energy requirements. Daily energy requirements were calculated from data from the
Lipid Research Clinics Prevalence Study with 1254kJ (300kcal) added for weight maintenance or 836kJ
subtracted for weight loss (BMI >27).
Comparison interventions: High GI breakfast cereal. Treatment as for low GI diet. Assessment of dietary
compliance: Compliance was assessed as the difference between the amount of treatment food provided
at the previous clinic visit and the amount returned at the present visit.
Comparison of total energy and macronutrient intakes: Reported
Outcomes Main outcomes:
Body weight, fasting glucose, glycosylated haemoglobin, total cholesterol, LDL cholesterol, HDL choles-
terol, triacylglycerols.
Other outcomes: 8-h metabolic profiles of plasma glucose, insulin, fatty acid, triacylglycerol and mean 8-
h plasma glucose, insulin, fatty acid and triacylglycerol concentrations.
Notes Calculated (mean) GI of diets: Low GI 75.8 %, High GI 86.1%
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Wolever 1992a
Methods Study design: Randomised cross-over study
Random allocation: Unclear
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 6 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Non-insulin dependent diabetes and obese/overweight.
Exclusion criteria: Not reported
Medications used: Not reported
Smoking status: Not reported
n = 6 randomised, 6 completed
Mean age: 63+/- 4 years.
Male/female ratio: 50%/50%
Baseline characteristics: Reported
Geographical location: Canada
Interventions Intervention: Low GI diet (reduced energy). Diets were designed to be moderately reduced in energy to
induce 0.5 to 1 kg weight loss/week. For the first and last two weeks of each dietary period, subjects were
provided with pre-weighed portions of all starchy foods, cheese and tinned sauces in their diets. Subjects
provided with a detailed daily menu plan.
Comparison interventions: High GI diet. Treatment as for low GI diet. Washout interval (for crossover
studies) : 4 to 6 weeks
Assessment of dietary compliance: Not reported
Comparison of total energy and macronutrient intakes: Reported
Outcomes Main outcomes: Body weight, fasting glucose, total cholesterol, triglycerides, HDL-cholesterol, LDL
cholesterol.
Other outcomes: fructosamine
Notes Calculated (mean) GI of diets: Low GI 58 %, High GI 86 %.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Wolever 2002
Methods Study design: RCT
Random allocation: Adequate (coin toss)
Allocation concealment: Unclear
Blinding of outcome assessors: Unclear
Length of intervention: 16 weeks
Unit of allocation: Participant
Unit of analysis: Participant
Protection against contamination: Unclear
Intention-to-treat analysis: Not done
Participants Diagnosis of CHD or risk factors: Subjects with impaired glucose tolerance and at least one risk factor for
diabetes.
Exclusion criteria: pregnancy, aged <30 or > 65 years, BMI > 40, serum triacylglycerol >10 mmol/L.
Medications used: Thiazide diuretics were used by one high GI subject. B-blockers were taken by one low
GI subject.
Smoking status: Not reported
n = 24 randomised, 22 completed
Control (High GI group): baseline n = 11, end n = 9. Intervention (Low GI) group: baseline n = 13, end
n = 13
Mean age: 55.6+/- 2.1
Male/female ratio: 20.6 %: 79.4 % (in 3 arms of study)
Baseline characteristics: Reported
Geographical location: Canada
Interventions Intervention: Low GI diet (high carbohydrate). Diets were prescribed on an ad libitum basis based on
two 3-day food records during the baseline period. The aim was for the diets to be weight maintaining.
Specific food products to be used in the diet were provided to subjects. Subjects were seen monthly for
consultations with a dietitian. Comparison interventions: High GI diet (high carbohydrate). Treatment
as for low GI diet.
Assessment of dietary compliance: 3-day food records completed monthly. Comparison of total energy
and macronutrient intakes: Reported
Outcomes Main outcomes: Body weight, fasting LDL cholesterol, diastolic blood pressure, fasting plasma glucose,
glycosylated haemoglobin, fasting total cholesterol, fasting triglycerides, HDL cholesterol
Other outcomes:
Insulin sensitivity, glucose effectiveness, pancreatic resposivity, glucose disposition index, postprandial
plasma glucose, insulin, triacylglycerol, free fatty acids
Notes Calculated (mean) GI of diets: Low GI 54.4% +/- 0.7 (SE), High GI diet 59.3 +/- 0.6 (SE).
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Taghrid 2003 study. Information based on two short abstracts and unpublished data provided by the authors. A further full paper is
due for submission late 2003.
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Calle-Pascual 1988 - The study design is not clear from the published details but the authors (A.L. Calle-Pascual) have confirmed to
us that the study was of open, randomised cross-over design.
AUC = Area under curve data
Characteristics of excluded studies [ordered by study ID]
Abbasi 2000 Participants not diagnosed with CHD or at risk of CHD
GI of the diet not reported or compared
Intervention < 4 weeks
Agus 2000 Intervention < 4 weeks
Alfenas 2005 Intervention < 4 weeks
Participants not diagnosed with CHD or at risk of CHD
Participants not free-living
Bahadori 2005 Not an RCT
Barkoukis 2002 Participants not diagnosed with CHD or at risk of CHD
Intervention < 4 weeks
Brynes 2003 Intervention < 4 weeks
Chanteleau 1985 Intervention < 4 weeks
Clapp 1998 Participants not diagnosed with CHD or at risk of CHD
Participants pregnant
Colagiuri 1986 Intervention < 4 weeks
GI of diets not reported or compared
Collier 1986 Comparison not between diets with similar overall energy and macronutrient contents
Intervention < 4 weeks
CHD mortality, morbidity or risk factor outcomes not reported
Collier 1988 Intervention in children
Coulston 1984 Intervention < 4 weeks
Crapo 1981 GI of diets not reported or compared
Participants not free-living
Intervention < 4 weeks
Dumesnil 2001 Comparison not between diets with similar energy and macronutrient contents
Participants not free-living
Intervention < 4 weeks
Ebbeling 2003 Comparison not between diets with similar energy and macronutrient contents
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(Continued)
Ebbeling 2005 Comparison not between diets with similar energy and macronutrient contents
Fontvielle 1988 Intervention < 4 weeks
Frost 1998a Intervention < 4 weeks
Frost 1998b Not a dietary intervention
Frost 1999b Not an RCT or CCT
Fuh 1990 Participants not free-living
GI of diets not reported or compared
Comparison not between diets with similar overall energy and macronutrient levels
Intervention < 4 weeks
Garg 1988 GI of diets not reported or compared
Participants not free-living
Garg 1992 GI of diets not reported or compared
Comparison not between diets with similar overall energy and macronutrient intakes
Participants not free-living
Intervention < 4 weeks
Garg 1994 GI of diets not reported or compared
Gilbertson 2001 Participants are children
Gilbertson 2003 Study does not report CHD risk factors or outcomes
Golay 1992 Intervention < 4 weeks
Herrmann 2001 Participants not diagnosed with CHD or at risk of CHD
Intervention < 4 weeks
Hollenbeck 1985 GI of diets not reported or compared
Comparisons not between diets with similar overall energy and macronutrient levels
Jarvi 1995 Intervention < 4 weeks
Jarvi 1999 Intervention < 4 weeks
Jenkins 1985 Not RCT or CCT
Jenkins 1987a Participants not diagnosed with CHD or at risk of CHD
Intervention < 4 weeks
Jenkins 1987b Not RCT or CCT
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(Continued)
Jenkins 1988 Intervention < 4 weeks
Jenkins 2002a GI of diets not reported or compared
Participants not free-living
Jenkins 2002b Intervention < 4 weeks
Jeppesen 1997 Participants not diagnosed with CHD or at risk of CHD
GI of diets not reported or compared
Comparisons not between diets with similar overall energy and macronutrient contents
Intervention < 4 weeks
Jiminez-Cruz 2003b Intervention < 4 weeks
Jiminez-Cruz 2004 Intervention < 4 weeks
Kiens 1996 Participants not diagnosed with CHD or at risk of CHD
Lafrance 1998 Intervention < 4 weeks
LaHaye 2005 Not an RCT
Laitinen 1993 GI of diets not reported or compared
Leinonen 2000 GI of diet not reported or compared
Lerman-Garber 1995 GI of diets not reported or compared
Comparison not between diets with similar overall energy and macronutrient contents
Lieberman 2003 Not an RCT
Liu 2000 Not RCT or CCT
Liu 2002a Not RCT or CCT
Ludwig 1999 Participants are children
Lunetta 1996 Intervention < 4 weeks
Participants not free-living
Morales 1997 Not RCT or CCT
Child
Pacy 1984 GI of diets not reported or compared
Comparison not between diets with similar overall energy and macronutrient contents
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(Continued)
Percheron 1997 Comparison not between diets with similar energy and macronutrient levels
Participants not free-living
Intervention < 4 weeks
Pereira 2002 GI of diets not reported or compared
Pereira 2004 Comparison not between diets with similar energy and macronutrient levels
Pittas 2005 Comparison not between diets with similar energy and macronutrient levels
Poppitt 2002 GI of the diets not reported or compared
Rabasa-Lhoret 1999 Comparison not between diets with similar overall energy and macronutrient levels.
Participants not free-living
Intervention < 4 weeks
Rasmussen 1993 GI of diets not reported or compared
Comparison not between diets with similar overall energy and macronutrient contents
Salmeron 1997 Not an RCT or CCT
Santacroce 1990 GI of diets not reported or compared
Scholz 2003 Intervention < 4 weeks
Sciarrone 1993 Participants not diagnosed with CHD or at risk of CHD
Sharafetdinov 1997 Intervention < 4 weeks
Singh 1991 GI of the diets not reported or compared
Comparison not between diets of similar energy and macronutrient intake
Slabber 1994 GI of the diets not reported or compared
Spieth 2000 Participants are children
Van Horn 1991 GI of diets not reported or compared
Wolever 1992b Intervention < 4 weeks
Wolever 1995 Participants not diagnosed with CHD or at risk of CHD
Intervention less than 4 weeks
Yang 2002 Not an RCT
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D A T A A N D A N A L Y S E S
Comparison 1. Total cholesterol (parallel and cross-over studies)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All endpoint outcomes (mmol/
L)
17 607 Mean Difference (IV, Fixed, 95% CI) -0.16 [-0.29, -0.02]
Comparison 2. Total cholesterol (whole-diet studies only, parallel and crossover studies)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 4 and 5 week outcomes (mmol/
L)
8 225 Mean Difference (IV, Fixed, 95% CI) -0.04 [-0.28, 0.20]
2 12 week outcomes (mmol/L) 4 162 Mean Difference (IV, Fixed, 95% CI) 0.01 [-0.26, 0.29]
3 All endpoint outcomes (mmol/
L)
15 535 Mean Difference (IV, Fixed, 95% CI) -0.17 [-0.32, -0.02]
Comparison 3. HDL cholesterol (parallel and cross-over studies)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All endpoint outcomes (mmol/
L)
16 Mean Difference (IV, Fixed, 95% CI) Subtotals only
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Comparison 4. HDL cholesterol (parallel studies only)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 4 and 5 week outcomes (mmol/
L)
3 89 Mean Difference (IV, Fixed, 95% CI) -0.11 [-0.20, -0.01]
2 12 week outcomes 4 Mean Difference (IV, Fixed, 95% CI) Subtotals only
Comparison 5. LDL cholesterol (parallel and cross-over studies)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All endpoint outcomes (mmol/
L)
14 482 Mean Difference (IV, Fixed, 95% CI) -0.15 [-0.30, 0.01]
2 All endpoint outcomes (without
Wolever 2002 study)
13 458 Mean Difference (IV, Fixed, 95% CI) -0.16 [-0.32, -0.00]
Comparison 6. Triglycerides (parallel and cross-over studies)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All endpoint data (mmol/L) 18 625 Mean Difference (IV, Fixed, 95% CI) 0.01 [-0.09, 0.11]
Comparison 7. Body weight (parallel and cross-over studies)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All endpoint outcomes (kg) 17 583 Mean Difference (IV, Fixed, 95% CI) 0.04 [-0.73, 0.82]
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Comparison 8. Fasting glucose (parallel and cross-over studies)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All endpoint outcomes (mmol/
L)
17 570 Mean Difference (IV, Fixed, 95% CI) 0.14 [0.02, 0.26]
Comparison 9. Fasting insulin (parallel and cross-over studies)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All endpoint outcomes 9 298 Mean Difference (IV, Fixed, 95% CI) -1.55 [-8.52, 5.43]
Comparison 10. HbA1c (parallel and cross-over studies)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All endpoint outcomes (%) 12 438 Mean Difference (IV, Fixed, 95% CI) -0.09 [-0.22, 0.04]
2 12 week outcomes (%) 4 157 Mean Difference (IV, Fixed, 95% CI) -0.11 [-0.28, 0.06]
3 12 week outcomes (%) without
Frost 1996
3 102 Mean Difference (IV, Fixed, 95% CI) -0.45 [-0.82, -0.09]
47Low glycaemic index diets for coronary heart disease (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.1. Comparison 1 Total cholesterol (parallel and cross-over studies), Outcome 1 All endpoint
outcomes (mmol/L).
Review: Low glycaemic index diets for coronary heart disease
Comparison: 1 Total cholesterol (parallel and cross-over studies)
Outcome: 1 All endpoint outcomes (mmol/L)
Study or subgroup Low GI High GI Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bouche 2002 11 4.9 (1.26) 11 5.3 (1.29) 1.7 % -0.40 [ -1.47, 0.67 ]
Brand 1991 16 5.79 (0.88) 16 5.8 (1) 4.4 % -0.01 [ -0.66, 0.64 ]
Fontvielle 1992 18 5.56 (0.88) 18 5.48 (0.23) 10.7 % 0.08 [ -0.34, 0.50 ]
Frost 1994 25 5.5 (1.6) 26 5.3 (0.51) 4.4 % 0.20 [ -0.46, 0.86 ]
Frost 1996 15 6.1 (1.1) 15 6.2 (1.2) 2.8 % -0.10 [ -0.92, 0.72 ]
Frost 2004 26 4.64 (0.82) 29 4.91 (1.02) 7.9 % -0.27 [ -0.76, 0.22 ]
Giacco 2000 29 4.7 (0.9) 25 5.1 (1.2) 5.7 % -0.40 [ -0.97, 0.17 ]
Heilbronn 2002 24 5.01 (0.83) 21 5.58 (0.87) 7.6 % -0.57 [ -1.07, -0.07 ]
Jimenez-Cruz 2003a 14 5.4 (0.86) 14 5.5 (0.9) 4.4 % -0.10 [ -0.75, 0.55 ]
Kabir 2002 13 5.1 (0.7) 13 5.2 (0.7) 6.5 % -0.10 [ -0.64, 0.44 ]
Luscombe 1999 21 5.38 (1.05) 21 5.44 (0.96) 5.1 % -0.06 [ -0.67, 0.55 ]
Patel 2004 18 6.01 (1.06) 17 6.02 (0.95) 4.2 % -0.01 [ -0.68, 0.66 ]
Sloth 2004 23 4.27 (0.86) 22 4.7 (0.84) 7.6 % -0.43 [ -0.93, 0.07 ]
Taghrid 2004 12 4.48 (1) 12 4.9 (0.69) 4.0 % -0.42 [ -1.11, 0.27 ]
Tsihlias 2000 25 5.05 (0.82) 21 5.11 (0.97) 6.8 % -0.06 [ -0.58, 0.46 ]
Wolever 1992a 6 6 (1.69) 6 6.74 (2.22) 0.4 % -0.74 [ -2.97, 1.49 ]
Wolever 2002 13 -0.1 (0.43) 11 -0.06 (0.43) 15.8 % -0.04 [ -0.39, 0.31 ]
Total (95% CI) 309 298 100.0 % -0.16 [ -0.29, -0.02 ]
Heterogeneity: Chi2 = 9.21, df = 16 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 2.25 (P = 0.025)
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Analysis 2.1. Comparison 2 Total cholesterol (whole-diet studies only, parallel and crossover studies),
Outcome 1 4 and 5 week outcomes (mmol/L).
Review: Low glycaemic index diets for coronary heart disease
Comparison: 2 Total cholesterol (whole-diet studies only, parallel and crossover studies)
Outcome: 1 4 and 5 week outcomes (mmol/L)
Study or subgroup Low GI High GI Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bouche 2002 11 4.9 (1.26) 11 5.3 (1.29) 5.0 % -0.40 [ -1.47, 0.67 ]
Fontvielle 1992 18 5.56 (0.88) 18 5.48 (0.23) 32.0 % 0.08 [ -0.34, 0.50 ]
Frost 1996 15 6.1 (1.1) 15 6.2 (1.2) 8.3 % -0.10 [ -0.92, 0.72 ]
Luscombe 1999 21 5.38 (1.05) 21 5.44 (0.96) 15.3 % -0.06 [ -0.67, 0.55 ]
Patel 2004 18 6.01 (1.06) 17 6.02 (0.95) 12.7 % -0.01 [ -0.68, 0.66 ]
Taghrid 2004 12 4.48 (1) 12 4.9 (0.69) 12.0 % -0.42 [ -1.11, 0.27 ]
Wolever 1992a 6 6.17 (2) 6 6.44 (1.91) 1.2 % -0.27 [ -2.48, 1.94 ]
Wolever 2002 13 0.3 (1.08) 11 0.1 (0.46) 13.5 % 0.20 [ -0.45, 0.85 ]
Total (95% CI) 114 111 100.0 % -0.04 [ -0.28, 0.20 ]
Heterogeneity: Chi2 = 2.53, df = 7 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 0.32 (P = 0.75)
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Analysis 2.2. Comparison 2 Total cholesterol (whole-diet studies only, parallel and crossover studies),
Outcome 2 12 week outcomes (mmol/L).
Review: Low glycaemic index diets for coronary heart disease
Comparison: 2 Total cholesterol (whole-diet studies only, parallel and crossover studies)
Outcome: 2 12 week outcomes (mmol/L)
Study or subgroup Low GI High GI Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Brand 1991 16 5.79 (0.88) 16 5.8 (1) 17.4 % -0.01 [ -0.66, 0.64 ]
Frost 1994 25 5.5 (1.6) 26 5.3 (0.51) 17.2 % 0.20 [ -0.46, 0.86 ]
Frost 2004 26 4.64 (0.82) 29 4.91 (1.02) 31.3 % -0.27 [ -0.76, 0.22 ]
Wolever 2002 13 0.27 (0.58) 11 0.08 (0.58) 34.2 % 0.19 [ -0.28, 0.66 ]
Total (95% CI) 80 82 100.0 % 0.01 [ -0.26, 0.29 ]
Heterogeneity: Chi2 = 2.17, df = 3 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 0.09 (P = 0.92)
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Analysis 2.3. Comparison 2 Total cholesterol (whole-diet studies only, parallel and crossover studies),
Outcome 3 All endpoint outcomes (mmol/L).
Review: Low glycaemic index diets for coronary heart disease
Comparison: 2 Total cholesterol (whole-diet studies only, parallel and crossover studies)
Outcome: 3 All endpoint outcomes (mmol/L)
Study or subgroup Low GI High GI Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bouche 2002 11 4.9 (1.26) 11 5.3 (1.29) 1.9 % -0.40 [ -1.47, 0.67 ]
Brand 1991 16 5.79 (0.88) 16 5.8 (1) 5.1 % -0.01 [ -0.66, 0.64 ]
Fontvielle 1992 18 5.56 (0.88) 18 5.48 (0.23) 12.3 % 0.08 [ -0.34, 0.50 ]
Frost 1994 25 5.5 (1.6) 26 5.3 (0.51) 5.0 % 0.20 [ -0.46, 0.86 ]
Frost 1996 15 6.1 (1.1) 15 6.2 (1.2) 3.2 % -0.10 [ -0.92, 0.72 ]
Frost 2004 26 4.64 (0.82) 29 4.91 (1.02) 9.2 % -0.27 [ -0.76, 0.22 ]
Giacco 2000 29 4.7 (0.9) 25 5.1 (1.2) 6.6 % -0.40 [ -0.97, 0.17 ]
Heilbronn 2002 24 5.01 (0.83) 21 5.58 (0.87) 8.7 % -0.57 [ -1.07, -0.07 ]
Jimenez-Cruz 2003a 14 5.4 (0.86) 14 5.5 (0.9) 5.1 % -0.10 [ -0.75, 0.55 ]
Luscombe 1999 21 5.38 (1.05) 21 5.44 (0.96) 5.9 % -0.06 [ -0.67, 0.55 ]
Patel 2004 18 6.01 (1.06) 17 6.02 (0.95) 4.9 % -0.01 [ -0.68, 0.66 ]
Sloth 2004 23 4.27 (0.86) 22 4.7 (0.84) 8.8 % -0.43 [ -0.93, 0.07 ]
Taghrid 2004 12 4.48 (1) 12 4.9 (0.69) 4.6 % -0.42 [ -1.11, 0.27 ]
Wolever 1992a 6 6 (1.69) 6 6.74 (2.22) 0.4 % -0.74 [ -2.97, 1.49 ]
Wolever 2002 13 -0.1 (0.43) 11 -0.06 (0.43) 18.2 % -0.04 [ -0.39, 0.31 ]
Total (95% CI) 271 264 100.0 % -0.17 [ -0.32, -0.02 ]
Heterogeneity: Chi2 = 9.01, df = 14 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 2.25 (P = 0.024)
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Analysis 3.1. Comparison 3 HDL cholesterol (parallel and cross-over studies), Outcome 1 All endpoint
outcomes (mmol/L).
Review: Low glycaemic index diets for coronary heart disease
Comparison: 3 HDL cholesterol (parallel and cross-over studies)
Outcome: 1 All endpoint outcomes (mmol/L)
Study or subgroup Low GI High GI Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bouche 2002 11 1.01 (0.26) 11 1.06 (0.03) -0.05 [ -0.20, 0.10 ]
Fontvielle 1992 18 1.16 (0.26) 18 1.09 (0.23) 0.07 [ -0.09, 0.23 ]
Frost 1994 25 1.2 (0.3) 26 1.1 (0.6) 0.10 [ -0.16, 0.36 ]
Frost 1996 15 1 (0.4) 15 1.01 (0.3) -0.01 [ -0.26, 0.24 ]
Frost 2004 26 1.1 (0.25) 29 1.11 (0.27) -0.01 [ -0.15, 0.13 ]
Giacco 2000 29 1.5 (0.3) 25 1.4 (0.4) 0.10 [ -0.09, 0.29 ]
Heilbronn 2002 24 1.26 (0.39) 21 1.12 (0.37) 0.14 [ -0.08, 0.36 ]
Jimenez-Cruz 2003a 14 1.22 (1.5) 14 1.24 (0.22) -0.02 [ -0.81, 0.77 ]
Kabir 2002 13 0.95 (0.28) 13 0.92 (0.28) 0.03 [ -0.19, 0.25 ]
Luscombe 1999 21 0.93 (0.18) 21 0.88 (0.18) 0.05 [ -0.06, 0.16 ]
Patel 2004 18 1.03 (0.3) 17 1.11 (0.29) -0.08 [ -0.28, 0.12 ]
Sloth 2004 23 1.49 (0.34) 22 1.52 (0.33) -0.03 [ -0.23, 0.17 ]
Taghrid 2004 12 1.29 (0.38) 12 1.28 (0.45) 0.01 [ -0.32, 0.34 ]
Tsihlias 2000 25 0.92 (0.27) 21 1.03 (0.38) -0.11 [ -0.30, 0.08 ]
Wolever 1992a 6 0.69 (0.15) 6 0.7 (0.15) -0.01 [ -0.18, 0.16 ]
Wolever 2002 13 -0.01 (0.11) 11 0.6 (0.16) -0.61 [ -0.72, -0.50 ]
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Analysis 4.1. Comparison 4 HDL cholesterol (parallel studies only), Outcome 1 4 and 5 week outcomes
(mmol/L).
Review: Low glycaemic index diets for coronary heart disease
Comparison: 4 HDL cholesterol (parallel studies only)
Outcome: 1 4 and 5 week outcomes (mmol/L)
Study or subgroup Low GI High GI Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Frost 1996 15 1 (0.4) 15 1.01 (0.3) 14.2 % -0.01 [ -0.26, 0.24 ]
Patel 2004 18 1.03 (0.3) 17 1.11 (0.29) 23.9 % -0.08 [ -0.28, 0.12 ]
Wolever 2002 13 -0.01 (0.14) 11 0.13 (0.16) 61.9 % -0.14 [ -0.26, -0.02 ]
Total (95% CI) 46 43 100.0 % -0.11 [ -0.20, -0.01 ]
Heterogeneity: Chi2 = 0.92, df = 2 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 2.20 (P = 0.028)
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Analysis 4.2. Comparison 4 HDL cholesterol (parallel studies only), Outcome 2 12 week outcomes.
Review: Low glycaemic index diets for coronary heart disease
Comparison: 4 HDL cholesterol (parallel studies only)
Outcome: 2 12 week outcomes
Study or subgroup Low GI High GI Mean Difference Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Frost 1994 25 1.2 (0.3) 26 1.1 (0.6) 0.10 [ -0.16, 0.36 ]
Frost 2004 26 1.1 (0.25) 29 1.11 (0.27) -0.01 [ -0.15, 0.13 ]
Tsihlias 2000 25 0.95 (0.27) 21 1.04 (0.38) -0.09 [ -0.28, 0.10 ]
Wolever 2002 13 -0.01 (0.14) 11 0.72 (0.16) -0.73 [ -0.85, -0.61 ]
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Analysis 5.1. Comparison 5 LDL cholesterol (parallel and cross-over studies), Outcome 1 All endpoint
outcomes (mmol/L).
Review: Low glycaemic index diets for coronary heart disease
Comparison: 5 LDL cholesterol (parallel and cross-over studies)
Outcome: 1 All endpoint outcomes (mmol/L)
Study or subgroup Low GI High GI Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bouche 2002 11 3.35 (1.06) 11 3.74 (0.7) 4.1 % -0.39 [ -1.14, 0.36 ]
Brand 1991 16 2.72 (0.76) 16 2.98 (0.92) 6.8 % -0.26 [ -0.84, 0.32 ]
Frost 1994 25 3.7 (1) 26 3.3 (1) 7.7 % 0.40 [ -0.15, 0.95 ]
Frost 1996 15 4.3 (1.2) 6 4.03 (1.49) 1.3 % 0.27 [ -1.07, 1.61 ]
Frost 2004 26 2.79 (0.71) 29 3 (0.81) 14.5 % -0.21 [ -0.61, 0.19 ]
Heilbronn 2002 24 2.91 (0.73) 21 2.91 (0.78) 11.9 % 0.0 [ -0.44, 0.44 ]
Jimenez-Cruz 2003a 14 3.2 (0.64) 14 3.4 (0.71) 9.3 % -0.20 [ -0.70, 0.30 ]
Luscombe 1999 21 3.79 (0.96) 21 3.75 (0.96) 6.9 % 0.04 [ -0.54, 0.62 ]
Patel 2004 18 4.24 (1.19) 17 4.25 (0.99) 4.5 % -0.01 [ -0.73, 0.71 ]
Sloth 2004 23 2.25 (0.72) 22 2.68 (0.7) 13.5 % -0.43 [ -0.84, -0.02 ]
Taghrid 2004 12 2.63 (0.9) 12 3.03 (0.73) 5.4 % -0.40 [ -1.06, 0.26 ]
Tsihlias 2000 25 2.85 (0.77) 21 3.12 (1.02) 8.3 % -0.27 [ -0.80, 0.26 ]
Wolever 1992a 6 4.04 (1.66) 6 4.41 (2.13) 0.5 % -0.37 [ -2.53, 1.79 ]
Wolever 2002 13 -0.1 (0.83) 11 -0.15 (0.83) 5.3 % 0.05 [ -0.62, 0.72 ]
Total (95% CI) 249 233 100.0 % -0.15 [ -0.30, 0.01 ]
Heterogeneity: Chi2 = 8.77, df = 13 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 1.89 (P = 0.058)
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Analysis 5.2. Comparison 5 LDL cholesterol (parallel and cross-over studies), Outcome 2 All endpoint
outcomes (without Wolever 2002 study).
Review: Low glycaemic index diets for coronary heart disease
Comparison: 5 LDL cholesterol (parallel and cross-over studies)
Outcome: 2 All endpoint outcomes (without Wolever 2002 study)
Study or subgroup Low GI High GI Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bouche 2002 11 3.35 (1.06) 11 3.74 (0.7) 4.4 % -0.39 [ -1.14, 0.36 ]
Brand 1991 16 2.72 (0.76) 16 2.98 (0.92) 7.2 % -0.26 [ -0.84, 0.32 ]
Frost 1994 25 3.7 (1) 26 3.3 (1) 8.2 % 0.40 [ -0.15, 0.95 ]
Frost 1996 15 4.3 (1.2) 6 4.03 (1.49) 1.4 % 0.27 [ -1.07, 1.61 ]
Frost 2004 26 2.79 (0.71) 29 3 (0.81) 15.3 % -0.21 [ -0.61, 0.19 ]
Heilbronn 2002 24 2.91 (0.73) 21 2.91 (0.78) 12.5 % 0.0 [ -0.44, 0.44 ]
Jimenez-Cruz 2003a 14 3.2 (0.64) 14 3.4 (0.71) 9.8 % -0.20 [ -0.70, 0.30 ]
Luscombe 1999 21 3.79 (0.96) 21 3.75 (0.96) 7.3 % 0.04 [ -0.54, 0.62 ]
Patel 2004 18 4.24 (1.19) 17 4.25 (0.99) 4.7 % -0.01 [ -0.73, 0.71 ]
Sloth 2004 23 2.25 (0.72) 22 2.68 (0.7) 14.3 % -0.43 [ -0.84, -0.02 ]
Taghrid 2004 12 2.63 (0.9) 12 3.03 (0.73) 5.7 % -0.40 [ -1.06, 0.26 ]
Tsihlias 2000 25 2.85 (0.77) 21 3.12 (1.02) 8.7 % -0.27 [ -0.80, 0.26 ]
Wolever 1992a 6 4.04 (1.66) 6 4.41 (2.13) 0.5 % -0.37 [ -2.53, 1.79 ]
Total (95% CI) 236 222 100.0 % -0.16 [ -0.32, 0.00 ]
Heterogeneity: Chi2 = 8.41, df = 12 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 1.98 (P = 0.048)
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Analysis 6.1. Comparison 6 Triglycerides (parallel and cross-over studies), Outcome 1 All endpoint data
(mmol/L).
Review: Low glycaemic index diets for coronary heart disease
Comparison: 6 Triglycerides (parallel and cross-over studies)
Outcome: 1 All endpoint data (mmol/L)
Study or subgroup Low GI High GI Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bouche 2002 11 1.5 (1.39) 11 1.37 (0.73) 1.1 % 0.13 [ -0.80, 1.06 ]
Brand 1991 16 1.67 (0.72) 16 1.57 (0.72) 3.9 % 0.10 [ -0.40, 0.60 ]
Fontvielle 1992 18 1.2 (0.6) 18 1.52 (0.9) 3.8 % -0.32 [ -0.82, 0.18 ]
Frost 1994 25 1.4 (1) 26 2.1 (1.1) 2.9 % -0.70 [ -1.28, -0.12 ]
Frost 1996 15 1.89 (1.2) 15 1.58 (1.1) 1.4 % 0.31 [ -0.51, 1.13 ]
Frost 2004 26 1.5 (0.61) 29 1.76 (1.02) 5.0 % -0.26 [ -0.70, 0.18 ]
Giacco 2000 29 0.86 (0.44) 25 0.87 (0.28) 25.5 % -0.01 [ -0.20, 0.18 ]
Heilbronn 2002 24 1.84 (0.68) 21 1.6 (0.5) 8.0 % 0.24 [ -0.11, 0.59 ]
Jimenez-Cruz 2003a 14 2.1 (0.78) 14 1.9 (0.71) 3.1 % 0.20 [ -0.35, 0.75 ]
Kabir 2002 13 1.7 (0.7) 13 1.7 (0.4) 5.0 % 0.0 [ -0.44, 0.44 ]
Luscombe 1999 21 1.47 (0.87) 21 1.8 (1.7) 1.4 % -0.33 [ -1.15, 0.49 ]
Patel 2004 18 1.92 (1.4) 17 1.8 (0.95) 1.5 % 0.12 [ -0.67, 0.91 ]
Raatz 2005 10 -0.4 (0.95) 9 -0.5 (0.63) 1.9 % 0.10 [ -0.62, 0.82 ]
Sloth 2004 23 1.18 (0.77) 22 1.11 (0.28) 8.5 % 0.07 [ -0.27, 0.41 ]
Taghrid 2004 12 1.21 (0.66) 12 1.32 (0.66) 3.4 % -0.11 [ -0.64, 0.42 ]
Tsihlias 2000 24 1.84 (0.68) 21 1.6 (0.5) 8.0 % 0.24 [ -0.11, 0.59 ]
Wolever 1992a 6 2.81 (0.86) 6 3.61 (1.76) 0.4 % -0.80 [ -2.37, 0.77 ]
Wolever 2002 13 0.02 (0.25) 11 0 (0.36) 15.1 % 0.02 [ -0.23, 0.27 ]
Total (95% CI) 318 307 100.0 % 0.01 [ -0.09, 0.11 ]
Heterogeneity: Chi2 = 15.69, df = 17 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 0.15 (P = 0.88)
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Analysis 7.1. Comparison 7 Body weight (parallel and cross-over studies), Outcome 1 All endpoint
outcomes (kg).
Review: Low glycaemic index diets for coronary heart disease
Comparison: 7 Body weight (parallel and cross-over studies)
Outcome: 1 All endpoint outcomes (kg)
Study or subgroup Low GI High GI Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bouche 2002 11 85.7 (9.6) 11 86.5 (9) 1.0 % -0.80 [ -8.58, 6.98 ]
Brand 1991 16 75.9 (14.4) 16 76 (14.4) 0.6 % -0.10 [ -10.08, 9.88 ]
Carels 2005 27 96.6 (15.9) 26 94.1 (15.1) 0.9 % 2.50 [ -5.85, 10.85 ]
Fontvielle 1992 18 70.5 (10) 18 70.7 (10) 1.4 % -0.20 [ -6.73, 6.33 ]
Frost 1994 25 84.8 (23.5) 26 82.9 (14.8) 0.5 % 1.90 [ -8.93, 12.73 ]
Frost 1996 15 80.17 (13.36) 15 83.2 (11.62) 0.8 % -3.03 [ -11.99, 5.93 ]
Giacco 2000 29 67 (11) 25 64 (11) 1.8 % 3.00 [ -2.88, 8.88 ]
Heilbronn 2002 24 87.3 (16.2) 21 88.4 (11.9) 0.9 % -1.10 [ -9.34, 7.14 ]
Jimenez-Cruz 2003a 14 90.1 (23.2) 14 92 (24.7) 0.2 % -1.90 [ -19.65, 15.85 ]
Komindr 2001 10 64.19 (13.28) 10 63.84 (12.93) 0.5 % 0.35 [ -11.14, 11.84 ]
Luscombe 1999 21 86.2 (12.4) 21 86.5 (12.8) 1.0 % -0.30 [ -7.92, 7.32 ]
Raatz 2005 10 -9.95 (3.6) 9 -9.3 (4.11) 5.0 % -0.65 [ -4.14, 2.84 ]
Sloth 2004 23 76.76 (8.47) 22 78.93 (6.85) 3.0 % -2.17 [ -6.66, 2.32 ]
Taghrid 2004 12 92.7 (8.7) 12 92.4 (8.7) 1.3 % 0.30 [ -6.66, 7.26 ]
Tsihlias 2000 25 79.45 (13.7) 21 76.45 (15.1) 0.9 % 3.00 [ -5.40, 11.40 ]
Wolever 1992a 6 83.1 (6.8) 6 83.2 (6.1) 1.1 % -0.10 [ -7.41, 7.21 ]
Wolever 2002 13 -0.29 (1.09) 11 -0.39 (1.09) 79.2 % 0.10 [ -0.78, 0.98 ]
Total (95% CI) 299 284 100.0 % 0.04 [ -0.73, 0.82 ]
Heterogeneity: Chi2 = 3.63, df = 16 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.11 (P = 0.91)
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Analysis 8.1. Comparison 8 Fasting glucose (parallel and cross-over studies), Outcome 1 All endpoint
outcomes (mmol/L).
Review: Low glycaemic index diets for coronary heart disease
Comparison: 8 Fasting glucose (parallel and cross-over studies)
Outcome: 1 All endpoint outcomes (mmol/L)
Study or subgroup Low GI High GI Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bouche 2002 11 5.36 (0.36) 11 5.26 (0.36) 15.7 % 0.10 [ -0.20, 0.40 ]
Brand 1991 16 7 (1.6) 16 7.1 (3.2) 0.5 % -0.10 [ -1.85, 1.65 ]
Fontvielle 1992 18 10.9 (5.1) 18 11.7 (4.7) 0.1 % -0.80 [ -4.00, 2.40 ]
Frost 1994 25 9.6 (3) 26 9.8 (3) 0.5 % -0.20 [ -1.85, 1.45 ]
Frost 1996 15 7.3 (1.16) 15 6.2 (0.77) 2.9 % 1.10 [ 0.40, 1.80 ]
Frost 2004 26 5.49 (0.82) 29 5.16 (0.51) 10.6 % 0.33 [ -0.04, 0.70 ]
Heilbronn 2002 24 6.47 (1.91) 21 6.08 (1.14) 1.7 % 0.39 [ -0.52, 1.30 ]
Jimenez-Cruz 2003a 14 8.9 (2.47) 14 10 (3.7) 0.3 % -1.10 [ -3.43, 1.23 ]
Kabir 2002 13 10.6 (1.1) 13 10.1 (2.5) 0.6 % 0.50 [ -0.98, 1.98 ]
Luscombe 1999 21 9.7 (3.2) 21 9.8 (3.7) 0.3 % -0.10 [ -2.19, 1.99 ]
Patel 2004 18 6.2 (0.85) 17 6.3 (1.24) 2.8 % -0.10 [ -0.81, 0.61 ]
Raatz 2005 10 -0.2 (0.32) 9 -0.3 (0.32) 17.1 % 0.10 [ -0.19, 0.39 ]
Sloth 2004 23 4.82 (0.29) 22 4.72 (0.33) 43.0 % 0.10 [ -0.08, 0.28 ]
Taghrid 2004 12 9.19 (2.42) 12 9.75 (1.97) 0.5 % -0.56 [ -2.33, 1.21 ]
Tsihlias 2000 25 9.2 (2.7) 21 8.8 (2.7) 0.6 % 0.40 [ -1.17, 1.97 ]
Wolever 1992a 6 8.4 (1.7) 6 8.4 (1.5) 0.4 % 0.0 [ -1.81, 1.81 ]
Wolever 2002 13 5.12 (0.97) 9 5.45 (0.93) 2.2 % -0.33 [ -1.13, 0.47 ]
Total (95% CI) 290 280 100.0 % 0.14 [ 0.02, 0.26 ]
Heterogeneity: Chi2 = 13.20, df = 16 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 2.24 (P = 0.025)
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Analysis 9.1. Comparison 9 Fasting insulin (parallel and cross-over studies), Outcome 1 All endpoint
outcomes.
Review: Low glycaemic index diets for coronary heart disease
Comparison: 9 Fasting insulin (parallel and cross-over studies)
Outcome: 1 All endpoint outcomes
Study or subgroup Low GI High GI Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bouche 2002 11 93.9 (50.4) 11 228.9 (423.5) 0.1 % -135.00 [ -387.03, 117.03 ]
Frost 1996 15 84 (62) 15 84 (58.1) 2.6 % 0.0 [ -43.00, 43.00 ]
Frost 2004 26 59.12 (23.1) 29 63.41 (25.5) 29.5 % -4.29 [ -17.13, 8.55 ]
Kabir 2002 13 117 (50.5) 13 102 (43.3) 3.7 % 15.00 [ -21.16, 51.16 ]
Luscombe 1999 21 98.62 (44.45) 21 86.12 (31.95) 8.9 % 12.50 [ -10.91, 35.91 ]
Patel 2004 18 73 (67.9) 17 84 (61.8) 2.6 % -11.00 [ -53.98, 31.98 ]
Raatz 2005 10 -28.5 (19.9) 9 -20.1 (21.8) 13.7 % -8.40 [ -27.24, 10.44 ]
Sloth 2004 23 33 (24) 22 34 (14.1) 37.1 % -1.00 [ -12.44, 10.44 ]
Taghrid 2004 12 122.5 (75.7) 12 124.5 (54) 1.8 % -2.00 [ -54.61, 50.61 ]
Total (95% CI) 149 149 100.0 % -1.55 [ -8.52, 5.43 ]
Heterogeneity: Chi2 = 4.15, df = 8 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 0.44 (P = 0.66)
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Analysis 10.1. Comparison 10 HbA1c (parallel and cross-over studies), Outcome 1 All endpoint outcomes
(%).
Review: Low glycaemic index diets for coronary heart disease
Comparison: 10 HbA1c (parallel and cross-over studies)
Outcome: 1 All endpoint outcomes (%)
Study or subgroup Low GI High GI Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Brand 1991 16 7 (1.2) 16 7.9 (2) 1.3 % -0.90 [ -2.04, 0.24 ]
Calle-Pascual 1988 24 8.8 (0.49) 24 8.81 (0.55) 19.7 % -0.01 [ -0.30, 0.28 ]
Fontvielle 1992 18 8.3 (1.4) 18 8.3 (1.5) 1.9 % 0.0 [ -0.95, 0.95 ]
Frost 2004 26 5.41 (0.41) 29 5.42 (0.32) 44.6 % -0.01 [ -0.21, 0.19 ]
Giacco 2000 29 8.8 (1) 25 9.1 (1.3) 4.4 % -0.30 [ -0.93, 0.33 ]
Heilbronn 2002 24 6.04 (1.37) 21 6.06 (0.87) 3.9 % -0.02 [ -0.68, 0.64 ]
Jimenez-Cruz 2003a 14 8.1 (0.9) 14 8.6 (0.9) 3.9 % -0.50 [ -1.17, 0.17 ]
Kabir 2002 13 7.8 (1.4) 13 7.9 (1.4) 1.5 % -0.10 [ -1.18, 0.98 ]
Komindr 2001 10 10.97 (1.55) 10 11.15 (2.02) 0.7 % -0.18 [ -1.76, 1.40 ]
Taghrid 2004 12 7.17 (1.35) 12 7.57 (1.21) 1.6 % -0.40 [ -1.43, 0.63 ]
Tsihlias 2000 25 7.98 (1.1) 21 8.28 (1.1) 4.2 % -0.30 [ -0.94, 0.34 ]
Wolever 2002 13 -0.08 (0.22) 11 0.04 (0.6) 12.2 % -0.12 [ -0.49, 0.25 ]
Total (95% CI) 224 214 100.0 % -0.09 [ -0.22, 0.04 ]
Heterogeneity: Chi2 = 5.62, df = 11 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 1.32 (P = 0.19)
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Analysis 10.2. Comparison 10 HbA1c (parallel and cross-over studies), Outcome 2 12 week outcomes (%).
Review: Low glycaemic index diets for coronary heart disease
Comparison: 10 HbA1c (parallel and cross-over studies)
Outcome: 2 12 week outcomes (%)
Study or subgroup Low GI High GI Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Brand 1991 16 7 (1.2) 16 7.9 (2) 2.3 % -0.90 [ -2.04, 0.24 ]
Frost 2004 26 5.41 (0.41) 29 5.42 (0.32) 77.7 % -0.01 [ -0.21, 0.19 ]
Tsihlias 2000 25 7.82 (1.1) 21 8.4 (1.1) 7.3 % -0.58 [ -1.22, 0.06 ]
Wolever 2002 13 5.52 (0.61) 11 5.82 (0.6) 12.7 % -0.30 [ -0.79, 0.19 ]
Total (95% CI) 80 77 100.0 % -0.11 [ -0.28, 0.06 ]
Heterogeneity: Chi2 = 5.51, df = 3 (P = 0.14); I2 =46%
Test for overall effect: Z = 1.23 (P = 0.22)
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Analysis 10.3. Comparison 10 HbA1c (parallel and cross-over studies), Outcome 3 12 week outcomes (%)
without Frost 1996.
Review: Low glycaemic index diets for coronary heart disease
Comparison: 10 HbA1c (parallel and cross-over studies)
Outcome: 3 12 week outcomes (%) without Frost 1996
Study or subgroup Low GI High GI Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Brand 1991 16 7 (1.2) 16 7.9 (2) 10.3 % -0.90 [ -2.04, 0.24 ]
Tsihlias 2000 25 7.82 (1.1) 21 8.4 (1.1) 32.9 % -0.58 [ -1.22, 0.06 ]
Wolever 2002 13 5.52 (0.61) 11 5.82 (0.6) 56.8 % -0.30 [ -0.79, 0.19 ]
Total (95% CI) 54 48 100.0 % -0.45 [ -0.82, -0.09 ]
Heterogeneity: Chi2 = 1.12, df = 2 (P = 0.57); I2 =0.0%
Test for overall effect: Z = 2.43 (P = 0.015)
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A P P E N D I C E S
Appendix 1. Search strategies
CENTRAL search
1. glyc?emic index.tw.
2. (glyc?emic adj3 low).tw.
3. (glyc?emic adj3 diet$).tw.
4. (carbohydrate$ adj25 diet$).ab,ti.
5. (starch$ adj25 diet$).ab,ti.
6. 1 or 2 or 3 or 4 or 5
7. coronary$.ab,ti.
8. cardiovascular$.ab,ti.
9. heart$.ab,ti.
10. chd.ab,ti.
11. angina.ab,ti.
12. cvd.ab,ti.
13. ischemic$.ab,ti.
14. myocardial$.ab,ti.
15. cardiac$.ab,ti.
16. lipid$.ab,ti.
17. cholesterol$.ab,ti.
18. blood pressure.ab,ti.
19. obes$.ab,ti.
20. diabet$.ab,ti.
21. glyc?emic.ab,ti.
22. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21
23. 6 and 22
24. random$.ab,ti.
25. compar$.ab,ti.
26. control$.ab,ti.
27. study.ab,ti.
28. follow$ up.ab,ti.
29. clinic$.ab,ti.
30. blind$.ab,ti.
31. double$.ab,ti.
32. cross?over.ab,ti.
33. 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32
34. 23 and 33
MEDLINE search
1. Glycemic Index/
2. (glyc?emic adj3 low).tw.
3. glyc?emic index.tw.
4. (glyc?emic adj3 diet$).tw.
5. 1 or 2 or 3 or 4
6. exp Dietary Carbohydrates/
7. CARBOHYDRATES/
8. carbohydrate$.tw.
9. starch*/
62Low glycaemic index diets for coronary heart disease (Review)
Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
10. or/6-9
11. exp Coronary Disease/
12. Cardiovascular Diseases/
13. heart disease$.tw.
14. coronary disease$.tw.
15. chd.tw.
16. cardiovascular.tw.
17. angina.tw.
18. cvd.tw.
19. 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18
20. 10 and 19
21. 5 or 20
22. randomized controlled trial.pt.
23. controlled clinical trial.pt.
24. Randomized controlled trials/
25. random allocation.sh.
26. double blind method.sh.
27. single-blind method.sh.
28. 22 or 23 or 24 or 25 or 26 or 27
29. (animal not human).sh.
30. 28 not 29
31. clinical trial.pt.
32. exp Clinical Trials/
33. (clin$ adj25 trial$).ab,ti.
34. ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)).ab,ti.
35. placebos.sh.
36. placebo$.ab,ti.
37. random$.ab,ti.
38. research design.sh.
39. 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38
40. 39 not 29
41. 40 not 30
42. comparative study.sh.
43. exp Evaluation Studies/
44. follow up studies.sh.
45. prospective studies.sh.
46. (control$ or prospectiv$ or volunteer$).ab,ti.
47. 42 or 43 or 44 or 45 or 46
48. 47 not 29
49. 48 not (30 or 41)
50. 30 or 41 or 49
51. 21 and 50
EMBASE search
1. (glyc?emic adj3 low).tw.
2. (glyc?emic adj3 diet$).tw.
3. glyc?emic index.tw,ti.
4. 1 or 2 or 3
5. exp Carbohydrate Diet/
6. Carbohydrate/
7. carbohydrate$.tw.
8. exp STARCH/
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9. 5 or 6 or 7 or 8
10. exp Ischemic Heart Disease/
11. exp Coronary Artery Disease/
12. Cardiovascular Disease/
13. heart disease$.tw.
14. coronary disease$.tw.
15. chd.tw.
16. cardiovascular.tw.
17. angina.tw.
18. cvd.tw.
19. 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18
20. 9 and 19
21. 4 or 20
22. Controlled Study/
23. Clinical Trial/
24. random$.ab,ti.
25. compar$.ab,ti.
26. control$.ab,ti.
27. study.ab,ti.
28. follow$ up.ab,ti.
29. clinic$.ab,ti.
30. blind$.ab,ti.
31. Double Blind Procedure/
32. double$.ab,ti.
33. 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32
34. 21 and 33
CINAHL search
1. exp Glycemic Index/
2. (glyc?emic adj3 low).tw.
3. glyc?emic index.tw.
4. (glyc?emic adj3 diet$).tw.
5. 1 or 2 or 3 or 4
6. exp Dietary Carbohydrates/
7. CARBOHYDRATES/
8. carbohydrate$.tw.
9. 6 or 7 or 8
10. exp Coronary Disease/
11. Cardiovascular Diseases/
12. heart disease$.tw.
13. chd.tw.
14. cardiovascular.tw.
15. angina.tw.
16. cvd.tw.
17. 10 or 11 or 12 or 13 or 14 or 15 or 16
18. 9 and 17
19. 5 or 18
20. clinical trial.pt.
21. exp Clinical Trials/
22. (clin$ adj25 trial$).tw.
23. ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)).tw.
24. PLACEBOS/
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25. placebo$.tw.
26. random$.tw.
27. exp Evaluation Research/
28. exp Prospective Studies/
29. Random Assignment/
30. Random Sample/
31. Crossover Design/
32. Comparative Studies/
33. 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32
34. 19 and 33
WH A T ’ S N E W
Last assessed as up-to-date: 14 May 2006.
15 May 2006 New search has been performed The search was updated to July 2006. Six new studies were identified and added
to the review. There is no change to the conclusions of the review.
H I S T O R Y
Protocol first published: Issue 4, 2003
Review first published: Issue 4, 2004
8 April 2008 Amended Converted to new review format.
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